<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ajpregu.physiology.org">
<title>AJP: Regulatory, Integrative and Comparative Physiology recent issues</title>
<link>http://ajpregu.physiology.org</link>
<description>AJP: Regulatory, Integrative and Comparative Physiology RSS feed -- recent issues</description>
<prism:eIssn>1522-1490</prism:eIssn>
<prism:publicationName>AJP: Regulatory, Integrative and Comparative Physiology</prism:publicationName>
<prism:issn>0363-6119</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1625?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/full/297/6/R1635?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1636?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/full/297/6/R1645?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1647?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1660?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1670?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1681?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1691?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1706?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1713?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1724?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1733?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1742?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1749?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1761?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1769?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1777?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1785?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1795?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1803?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1813?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1822?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1215?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1228?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1238?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1247?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1254?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1262?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1273?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1283?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1293?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1302?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1312?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1322?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1332?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1343?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1351?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1358?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1364?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1375?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1383?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1392?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1400?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1409?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1421?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1430?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1441?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1452?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1460?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1469?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1477?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1486?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1494?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1503?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1516?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1526?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1532?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1546?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1554?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1563?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1570?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1582?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1593?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1601?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1610?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1615?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/full/297/5/R1622?rss=1" />
  <rdf:li rdf:resource="http://ajpregu.physiology.org/cgi/content/full/297/5/R1624?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://ajpregu.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://ajpregu.physiology.org/icons/banner/title.gif">
<title>AJP: Regulatory, Integrative and Comparative Physiology</title>
<url>http://ajpregu.physiology.org/icons/banner/title.gif</url>
<link>http://ajpregu.physiology.org</link>
</image>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1625?rss=1">
<title><![CDATA[Comparative physiology of the pulmonary blood-gas barrier: the unique avian solution]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1625?rss=1</link>
<description><![CDATA[
<p>Two opposing selective pressures have shaped the evolution of the structure of the blood-gas barrier in air breathing vertebrates. The first pressure, which has been recognized for 100 years, is to facilitate diffusive gas exchange. This requires the barrier to be extremely thin and have a large area. The second pressure, which has only recently been appreciated, is to maintain the mechanical integrity of the barrier in the face of its extreme thinness. The most important tensile stress comes from the pressure within the pulmonary capillaries, which results in a hoop stress. The strength of the barrier can be attributed to the type IV collagen in the extracellular matrix. In addition, the stress is minimized in mammals and birds by complete separation of the pulmonary and systemic circulations. Remarkably, the avian barrier is about 2.5 times thinner than that in mammals and also is much more uniform in thickness. These advantages for gas exchange come about because the avian pulmonary capillaries are unique among air breathers in being mechanically supported externally in addition to the strength that comes from the structure of their walls. This external support comes from epithelial plates that are part of the air capillaries, and the support is available because the terminal air spaces in the avian lung are extremely small due to the flow-through nature of ventilation in contrast to the reciprocating pattern in mammals.</p>
]]></description>
<dc:creator><![CDATA[West, J. B.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00459.2009</dc:identifier>
<dc:title><![CDATA[Comparative physiology of the pulmonary blood-gas barrier: the unique avian solution]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1634</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1625</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/full/297/6/R1635?rss=1">
<title><![CDATA[Editorial Focus: Cardiac function of the lizard king: focus on "Ca2+ cycling in cardiomyocytes from a high-performance reptile, the varanid lizard (Varanus exanthematicus)"]]></title>
<link>http://ajpregu.physiology.org/cgi/content/full/297/6/R1635?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Quindry, J. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00618.2009</dc:identifier>
<dc:title><![CDATA[Editorial Focus: Cardiac function of the lizard king: focus on "Ca2+ cycling in cardiomyocytes from a high-performance reptile, the varanid lizard (Varanus exanthematicus)"]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1635</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1635</prism:startingPage>
<prism:section>Editorial Focus</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1636?rss=1">
<title><![CDATA[Ca2+ cycling in cardiomyocytes from a high-performance reptile, the varanid lizard (Varanus exanthematicus)]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1636?rss=1</link>
<description><![CDATA[
<p>The varanid lizard possesses one of the largest aerobic capacities among reptiles with maximum rates of oxygen consumption that are twice that of other lizards of comparable sizes at the same temperature. To support this aerobic capacity, the varanid heart possesses morphological adaptations that allow the generation of high heart rates and blood pressures. Specializations in excitation-contraction coupling may also contribute to the varanids superior cardiovascular performance. Therefore, we investigated the electrophysiological properties of the <scp>l</scp>-type Ca<sup>2+</sup> channel and the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX) and the contribution of the sarcoplasmic reticulum to the intracellular Ca<sup>2+</sup> transient ([Ca<sup>2+</sup>]<SUB>i</SUB>) in varanid lizard ventricular myocytes. Additionally, we used confocal microscopy to visualize myocytes and make morphological measurements. Lizard ventricular myocytes were found to be spindle-shaped, lack T-tubules, and were ~190 &micro;m in length and 5&ndash;7 &micro;m in width and depth. Cardiomyocytes had a small cell volume (~2 pL), leading to a large surface area-to-volume ratio (18.5), typical of ectothermic vertebrates. The voltage sensitivity of the <scp>l</scp>-type Ca<sup>2+</sup> channel current (<I>I</I><SUB>Ca</SUB>), steady-state activation and inactivation curves, and the time taken for recovery from inactivation were also similar to those measured in other reptiles and teleosts. However, transsarcolemmal Ca<sup>2+</sup> influx via reverse mode Na<sup>+</sup>/Ca<sup>2+</sup> exchange current was fourfold higher than most other ectotherms. Moreover, pharmacological inhibition of the sarcoplasmic reticulum led to a 40% reduction in the [Ca<sup>2+</sup>]<SUB>i</SUB> amplitude, and slowed the time course of decay. In aggregate, our results suggest varanids have an enhanced capacity to transport Ca<sup>2+</sup> through the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger, and sarcoplasmic reticulum suggesting specializations in excitation-contraction coupling may provide a means to support high cardiovascular performance.</p>
]]></description>
<dc:creator><![CDATA[Galli, G. L. J., Warren, D. E., Shiels, H. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00381.2009</dc:identifier>
<dc:title><![CDATA[Ca2+ cycling in cardiomyocytes from a high-performance reptile, the varanid lizard (Varanus exanthematicus)]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1644</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1636</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/full/297/6/R1645?rss=1">
<title><![CDATA[Using phenotypic plasticity: focus on "Identification of renal transporters involved in sulfate excretion in marine teleost fish"]]></title>
<link>http://ajpregu.physiology.org/cgi/content/full/297/6/R1645?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Grosell, M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00322.2009</dc:identifier>
<dc:title><![CDATA[Using phenotypic plasticity: focus on "Identification of renal transporters involved in sulfate excretion in marine teleost fish"]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1646</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1645</prism:startingPage>
<prism:section>Editorial Focus</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1647?rss=1">
<title><![CDATA[Identification of renal transporters involved in sulfate excretion in marine teleost fish]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1647?rss=1</link>
<description><![CDATA[
<p>Sulfate (SO<f><SUB>4</SUB><sup>2&ndash;</sup></f>) is the second most abundant anion in seawater (SW), and excretion of excess SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> from ingested SW is essential for marine fish to survive. Marine teleosts excrete SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> via the urine produced in the kidney. The SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> transporter that secretes and concentrates SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> in the urine has not previously been identified. Here, we have identified and characterized candidates for the long-sought transporters. Using sequences from the fugu database, we have cloned cDNA fragments of all transporters belonging to the Slc13 and Slc26 families from mefugu (<I>Takifugu obscurus</I>). We compared Slc13 and Slc26 mRNA expression in the kidney between freshwater (FW) and SW mefugu. Among 14 clones examined, the expression of a Slc26a6 paralog (mfSlc26a6A) was the most upregulated (30-fold) in the kidney of SW mefugu. Electrophysiological analyses of <I>Xenopus</I> oocytes expressing mfSlc26a6A, mfSlc26a6B, and mouse Slc26a6 (mSlc26a6) demonstrated that all transporters mediate electrogenic Cl<sup>&ndash;</sup>/SO<f><SUB>4</SUB><sup>2&ndash;</sup></f>, Cl<sup>&ndash;</sup>/oxalate<sup>2&ndash;</sup>, and Cl<sup>&ndash;</sup>/<I>n</I>HCO<SUB>3</SUB><sup>&ndash;</sup> exchanges and electroneutral Cl<sup>&ndash;</sup>/formate<sup>&ndash;</sup> exchange. Two-electrode voltage-clamp experiments demonstrated that the SO<f><SUB>4</SUB><sup>2&ndash;</sup></f>-elicited currents of mfSlc26a6A is quite large (~35 &micro;A at +60 mV) and 50- to 200-fold higher than those of mfSlc26a6B and mSlc26a6. Conversely, the currents elicited by oxalate and HCO<SUB>3</SUB><sup>&ndash;</sup> are almost identical among mfSlc26a6A, mfSlc26a6B, and mSlc26a6. Kinetic analysis revealed that mfSlc26a6A has the highest SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> affinity as well as capacity. Immunohistochemical analyses demonstrated that mfSlc26a6A localizes to the apical (brush-border) region of the proximal tubules. Together, these findings suggest that mfSlc26a6A is the most likely candidate for the major apical SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> transporter that mediates SO<f><SUB>4</SUB><sup>2&ndash;</sup></f> secretion in the kidney of marine teleosts.</p>
]]></description>
<dc:creator><![CDATA[Kato, A., Chang, M.-H., Kurita, Y., Nakada, T., Ogoshi, M., Nakazato, T., Doi, H., Hirose, S., Romero, M. F.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00228.2009</dc:identifier>
<dc:title><![CDATA[Identification of renal transporters involved in sulfate excretion in marine teleost fish]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1659</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1647</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1660?rss=1">
<title><![CDATA[Renal dopaminergic defect in C57Bl/6J mice]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1660?rss=1</link>
<description><![CDATA[
<p>The C57Bl/6J mouse strain, the genetic background of many transgenic and gene knockout models, is salt sensitive and resistant to renal injury. We tested the hypothesis that renal dopaminergic function is defective in C57Bl/6J mice. On normal NaCl (0.8%, 1 wk) diet, anesthetized and conscious (telemetry) blood pressures were similar in C57Bl/6J and SJL/J mice. High NaCl (6%, 1 wk) increased blood pressure (30%) in C57Bl/6J but not in SJL/J mice and urinary dopamine to greater extent in SJL/J than in C57Bl/6J mice. Absolute and fractional sodium excretions were lower in SJL/J than in C57Bl/6J mice. The blood pressure-natriuresis plot was shifted to the right in C57Bl/6J mice. Renal expressions of D<SUB>1</SUB>-like (D<SUB>1</SUB>R and D<SUB>5</SUB>R) and angiotensin II AT<SUB>1</SUB> receptors were similar on normal salt, but high salt increased D<SUB>5</SUB>R only in C57Bl/6J. GRK4 expression was lower on normal but higher on high salt in C57Bl/6J than in SJL/J mice. Salt increased the excretion of microalbumin and 8-isoprostane (oxidative stress marker) and the degree of renal injury to a greater extent in SJL/J than in C57Bl/6J mice. A D<SUB>1</SUB>-like receptor agonist increased sodium excretion whereas a D<SUB>1</SUB>-like receptor antagonist decreased sodium excretion in SJL/J but not in C57Bl/6J mice. In contrast, parathyroid hormone had a similar natriuretic effect in both strains. These results show that defective D<SUB>1</SUB>-like receptor function is a major cause of salt sensitivity in C57Bl/6J mice, decreased renal dopamine production might also contribute. The relative resistance to renal injury of C57Bl/6J may be a consequence of decreased production of reactive oxygen species.</p>
]]></description>
<dc:creator><![CDATA[Escano, C. S., Armando, I., Wang, X., Asico, L. D., Pascua, A., Yang, Y., Wang, Z., Lau, Y.-S., Jose, P. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00147.2009</dc:identifier>
<dc:title><![CDATA[Renal dopaminergic defect in C57Bl/6J mice]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1669</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1660</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1670?rss=1">
<title><![CDATA[Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1670?rss=1</link>
<description><![CDATA[
<p>Hemorrhagic shock (HS) due to major trauma predisposes the host to the development of acute lung inflammation and injury. The lung vascular endothelium is an active organ that plays a central role in the development of acute lung injury through generating reactive oxygen species and synthesizing and releasing of a number of inflammatory mediators, including leukocyte adhesion molecules that regulate neutrophils emigration. Previous study from our laboratory has demonstrated that in a setting of sepsis, Toll-like receptor-4 (TLR4) signaling can induce TLR2 expression in endothelial cells (ECs), thereby increasing the cells' response to TLR2 ligands. The present study tested the hypothesis that TLR4 activation by HS and the resultant increased TLR2 surface expression in ECs might contribute to the mechanism underlying HS-augmented activation of lung ECs. The results show that high-mobility group box 1 (HMGB1) through TLR4 signaling mediates HS-induced surface expression of TLR2 in the lung and mouse lung vascular endothelial cells (MLVECs). Furthermore, the results demonstrate that HMGB1 induces activation of NAD(P)H oxidase and expression of ICAM-1 in the lung, and MLVECs sequentially depend on TLR4 in the early phase and on TLR2 in the late phase following HS. Finally, the data indicate an important role of the increased TLR2 surface expression in enhancing the activation of MLVECs and augmenting pulmonary neutrophil infiltration in response to TLR2 agonist peptidoglycan. Thus, induction of TLR2 surface expression in lung ECs, induced by HS and mediated by HMGB1/TLR4 signaling, is an important mechanism responsible for endothelial cell-mediated inflammation and organ injury following trauma and hemorrhage.</p>
]]></description>
<dc:creator><![CDATA[Li, Y., Xiang, M., Yuan, Y., Xiao, G., Zhang, J., Jiang, Y., Vodovotz, Y., Billiar, T. R., Wilson, M. A., Fan, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00445.2009</dc:identifier>
<dc:title><![CDATA[Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1680</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1670</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1681?rss=1">
<title><![CDATA[Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1681?rss=1</link>
<description><![CDATA[
<p>Activation of the protease-activated receptor 2 (PAR2) or the transient receptor potential vanilloid type 1 (TRPV1) channels expressed in cardiac sensory afferents containing calcitonin gene-related peptide (CGRP) and/or substance P (SP) has been proposed to play a protective role in myocardial ischemia-reperfusion (I/R) injury. However, the interaction between PAR2 and TRPV1 is largely unknown. Using gene-targeted TRPV1-null mutant (TRPV1<sup>&ndash;/&ndash;</sup>) or wild-type (WT) mice, we test the hypothesis that TRPV1 contributes to PAR2-mediated cardiac protection via increasing the release of CGRP and SP. Immunofluorescence labeling showed that TRPV1 coexpressed with PAR2, PKC-, or PKAc in cardiomyocytes, cardiac blood vessels, and perivascular nerves in WT but not TRPV1<sup>&ndash;/&ndash;</sup> hearts. WT or TRPV1<sup>&ndash;/&ndash;</sup> hearts were Langendorff perfused with the selective PAR2 agonist, SLIGRL, in the presence or absence of various antagonists, followed by 35 min of global ischemia and 40 min of reperfusion (I/R). The recovery rate of coronary flow, the maximum rate of left ventricular pressure development, left ventricular end-diastolic pressure, and left ventricular developed pressure were evaluated after I/R. SLIGRL improved the recovery of hemodynamic parameters, decreased lactate dehydrogenase release, and reduced the infarct size in both WT and TRPV1<sup>&ndash;/&ndash;</sup> hearts (<I>P</I> &lt; 0.05). The protection of SLIGRL was significantly surpassed for WT compared with TRPV1<sup>&ndash;/&ndash;</sup> hearts (<I>P</I> &lt; 0.05). CGRP<SUB>8&ndash;37</SUB>, a selective CGRP receptor antagonist, RP67580, a selective neurokinin-1 receptor antagonist, PKC- V1&ndash;2, a selective PKC- inhibitor, or H-89, a selective PKA inhibitor, abolished SLIGRL protection by inhibiting the recovery of the rate of coronary flow, maximum rate of left ventricular pressure development, and left ventricular developed pressure, and increasing left ventricular end-diastolic pressure in WT but not TRPV1<sup>&ndash;/&ndash;</sup> hearts. Radioimmunoassay showed that SLIGRL increased the release of CGRP and SP in WT but not TRPV1<sup>&ndash;/&ndash;</sup> hearts (<I>P</I> &lt; 0.05), which were prevented by PKC- V1&ndash;2 and H-89. Thus our data show that PAR2 activation improves cardiac recovery after I/R injury in WT and TRPV1<sup>&ndash;/&ndash;</sup> hearts, with a greater effect in the former, suggesting that PAR2-mediated protection is TRPV1 dependent and independent, and that dysfunctional TRPV1 impairs PAR2 action. PAR2 activation of the PKC- or PKA pathway stimulates or sensitizes TRPV1 in WT hearts, leading to the release of CGRP and SP that contribute, at least in part, to PAR2-induced cardiac protection against I/R injury.</p>
]]></description>
<dc:creator><![CDATA[Zhong, B., Wang, D. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90746.2008</dc:identifier>
<dc:title><![CDATA[Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1690</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1681</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1691?rss=1">
<title><![CDATA[Absorption kinetics are a key factor regulating postprandial protein metabolism in response to qualitative and quantitative variations in protein intake]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1691?rss=1</link>
<description><![CDATA[
<p>We have previously demonstrated that increasing the habitual protein intake widened the gap in nutritional quality between proteins through mechanisms that are not yet fully understood. We hypothesized that the differences in gastrointestinal kinetics between dietary proteins were an important factor affecting their differential response to an increased protein intake. To test this hypothesis, we built a 13-compartment model providing integrative insight into the sequential dynamics of meal nitrogen (Nm) absorption, splanchnic uptake, and metabolism, and subsequent peripheral transfer and deposition. The model was developed from data on postprandial Nm kinetics in certain accessible pools, obtained from subjects having ingested a <sup>15</sup>N-labeled milk or soy protein meal, after adaptation to normal (NP) or high (HP) protein diets. The faster absorption of Nm after soy vs. milk caused its earlier and stronger splanchnic delivery, which favored its local catabolic utilization (up to +30%) and limited its peripheral accretion (down to &ndash;20%). Nm absorption was also accelerated after HP vs. NP adaptation, and this kinetic effect accounted for most of the HP-induced increase (up to +20%) in splanchnic Nm catabolic use, and the decrease (down to &ndash;25%) in peripheral Nm anabolic utilization. The HP-induced acceleration in Nm absorption was more pronounced with soy than with milk, as were the HP effects on Nm regional metabolism. Our integrative approach identified Nm absorption kinetics, which exert a direct and lasting impact on Nm splanchnic catabolic use and peripheral delivery, as being critical in adaptation to both qualitative and quantitative changes in protein intake.</p>
]]></description>
<dc:creator><![CDATA[Fouillet, H., Juillet, B., Gaudichon, C., Mariotti, F., Tome, D., Bos, C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00281.2009</dc:identifier>
<dc:title><![CDATA[Absorption kinetics are a key factor regulating postprandial protein metabolism in response to qualitative and quantitative variations in protein intake]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1705</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1691</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1706?rss=1">
<title><![CDATA[Plasma hyperosmolality elevates the internal temperature threshold for active thermoregulatory vasodilation during heat stress in humans]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1706?rss=1</link>
<description><![CDATA[
<p>Plasma hyperosmolality delays the response in skin blood flow to heat stress by elevating the internal temperature threshold for cutaneous vasodilation. This elevation could be because of a delayed onset of cutaneous active vasodilation and/or to persistent cutaneous active vasoconstriction. Seven healthy men were infused with either hypertonic (3% NaCl) or isotonic (0.9% NaCl) saline and passively heated by immersing their lower legs in 42&deg;C water for 60 min (room temperature, 28&deg;C; relative humidity, 40%). Skin blood flow was monitored via laser-Doppler flowmetry at sites pretreated with bretylium tosylate (BT) to block sympathetic vasoconstriction selectively and at adjacent control sites. Plasma osmolality was increased by ~13 mosmol/kgH<SUB>2</SUB>O following hypertonic saline infusion and was unchanged following isotonic saline infusion. The esophageal temperature (T<SUB>es</SUB>) threshold for cutaneous vasodilation at untreated sites was significantly elevated in the hyperosmotic state (37.73 &plusmn; 0.11&deg;C) relative to the isosmotic state (36.63 &plusmn; 0.12&deg;C, <I>P</I> &lt; 0.001). A similar elevation of the T<SUB>es</SUB> threshold for cutaneous vasodilation was observed between osmotic conditions at the BT-treated sites (37.74 &plusmn; 0.18 vs. 36.67 &plusmn; 0.07&deg;C, <I>P</I> &lt; 0.001) as well as sweating. These results suggest that the hyperosmotically induced elevation of the internal temperature threshold for cutaneous vasodilation is due primarily to an elevation in the internal temperature threshold for the onset of active vasodilation, and not to an enhancement of vasoconstrictor activity.</p>
]]></description>
<dc:creator><![CDATA[Shibasaki, M., Aoki, K., Morimoto, K., Johnson, J. M., Takamata, A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00242.2009</dc:identifier>
<dc:title><![CDATA[Plasma hyperosmolality elevates the internal temperature threshold for active thermoregulatory vasodilation during heat stress in humans]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1712</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1706</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1713?rss=1">
<title><![CDATA[Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1713?rss=1</link>
<description><![CDATA[
<p>The risk for cardiovascular disease (CVD) increases with advancing age; however, the age at which CVD risk increases significantly is delayed by more than a decade in women compared with men. This cardioprotection, which women experience until menopause, is presumably due to the presence of ovarian hormones, in particular, estrogen. The purpose of this study was to determine how age and ovarian hormones affect flow-induced vasodilation in the coronary resistance vasculature. Coronary arterioles were isolated from young (6 mo), middle-aged (14 mo), and old (24 mo) intact, ovariectomized (OVX), and ovariectomized + estrogen replaced (OVE) female Fischer-344 rats to assess flow-induced vasodilation. Advancing age impaired flow-induced dilation of coronary arterioles (young: 50 &plusmn; 4 vs. old: 34 &plusmn; 6; % relaxation). Ovariectomy reduced flow-induced dilation in arterioles from young females, and estrogen replacement restored vasodilation to flow. In aged females, flow-induced vasodilation of arterioles was unaltered by OVX; however, estrogen replacement improved flow-induced dilation by ~160%. The contribution of nitric oxide (NO) to flow-induced dilation, assessed by nitric oxide synthase (NOS) inhibition with <I>N</I><sup>G</sup>-nitro-<scp>l</scp>-arginine methyl ester (<scp>l</scp>-NAME), declined with age. <scp>l</scp>-NAME did not alter flow-induced vasodilation in arterioles from OVX rats, regardless of age. In contrast, <scp>l</scp>-NAME reduced flow-induced vasodilation of arterioles from estrogen-replaced rats at all ages. These findings indicate that the age-induced decline of flow-induced, NO-mediated dilation in coronary arterioles of female rats is related, in part, to a loss of ovarian estrogen, and estrogen supplementation can improve flow-induced dilation, even at an advanced age.</p>
]]></description>
<dc:creator><![CDATA[LeBlanc, A. J., Reyes, R., Kang, L. S., Dailey, R. A., Stallone, J. N., Moningka, N. C., Muller-Delp, J. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00178.2009</dc:identifier>
<dc:title><![CDATA[Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1723</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1713</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1724?rss=1">
<title><![CDATA[CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1724?rss=1</link>
<description><![CDATA[
<p>Multiple signals have been shown to be involved in regulation of fatty acid (FA) and glucose metabolism in contracting skeletal muscle. This study aimed to determine whether a Ca<sup>2+</sup>-stimulated kinase, CaMKK, is involved in regulation of contraction-induced substrate metabolism and whether it does so in an AMP-activated protein kinase (AMPK)-dependent manner. Rat hindlimbs were perfused at rest (<I>n</I> = 16), with 3 mM caffeine (<I>n</I> = 15), with 2 mM 5-aminoimidazole-4-carboxamide 1-&beta;-<scp>d</scp>-ribofuranoside (AICAR; <I>n</I> = 16), or during moderate-intensity muscle contraction (MC; <I>n</I> = 14) and with or without 5 &micro;M STO-609, a CaMKK inhibitor. FA uptake and oxidation increased (<I>P</I> &lt; 0.05) 64% and 71% by caffeine, 42% and 93% by AICAR, and 65% and 143% by MC. STO-609 abolished (<I>P</I> &lt; 0.05) caffeine- and MC-induced FA uptake and oxidation but had no effect with AICAR treatment. Glucose uptake increased (<I>P</I> &lt; 0.05) 104% by caffeine, 85% by AICAR, and 130% by MC, and STO-609 prevented the increase in glucose uptake in caffeine and muscle contraction groups. CaMKK&beta; activity increased (<I>P</I> &lt; 0.05) 113% by caffeine treatment and 145% by MC but was not affected by AICAR treatment. STO-609 prevented the caffeine- and MC-induced increase in CaMKK&beta; activity. Caffeine, AICAR, and MC increased (<I>P</I> &lt; 0.05) AMPK2 activity by 295%, 11-fold, and 7-fold but did not affect AMPK1 activity. STO-609 decreased (<I>P</I> &lt; 0.05) AMPK2 activity induced by caffeine treatment and MC by 60% and 61% but did not affect AICAR-induced activity. Plasma membrane transport protein content of CD36 and glucose transporter 4 (GLUT4) increased (<I>P</I> &lt; 0.05) with caffeine, AICAR, and MC, and STO-609 prevented caffeine- and MC-induced increases in protein content. These results show the importance of Ca<sup>2+</sup>-dependent signaling via CaMKK activation in the regulation of substrate uptake and FA oxidation in contracting rat skeletal muscle and agree with the notion that CaMKK is an upstream kinase of AMPK in the regulation of substrate metabolism in skeletal muscle.</p>
]]></description>
<dc:creator><![CDATA[Abbott, M. J., Edelman, A. M., Turcotte, L. P.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00179.2009</dc:identifier>
<dc:title><![CDATA[CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1732</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1724</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1733?rss=1">
<title><![CDATA[Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1733?rss=1</link>
<description><![CDATA[
<p>Several pathophysiological conditions, including nephrotic syndrome, are characterized by increased renal activity of the epithelial Na<sup>+</sup> channel (ENaC). We recently identified plasmin in nephrotic urine as a stimulator of ENaC activity and undertook this study to investigate the mechanism by which plasmin stimulates ENaC activity. Cy3-labeled plasmin was found to bind to the surface of the mouse cortical collecting duct cell line, M-1. Binding depended on a glycosylphosphatidylinositol (GPI)-anchored protein. Biotin-label transfer showed that plasmin interacted with the GPI-anchored protein prostasin on M-1 cells and that plasmin cleaved prostasin. Prostasin activates ENaC by cleavage of the -subunit, which releases an inhibitory peptide from the extracellular domain. Removal of GPI-anchored proteins from the M-1 cells with phosphatidylinositol-specific phospholipase C (PI-PLC) inhibited plasmin-stimulated ENaC current in monolayers of M-1 cells at low plasmin concentration (1&ndash;4 &micro;g/ml). At a high plasmin concentration of 30 &micro;g/ml, there was no difference between cell layers treated with or without PI-PLC. Knockdown of prostasin attenuated binding of plasmin to M1 cells and blocked plasmin-stimulated ENaC current in single M-1 cells, as measured by whole-cell patch clamp. In M-1 cells expressing heterologous FLAG-tagged prostasin, ENaC and prostasin were colocalized. A monoclonal antibody directed against the inhibitory peptide of ENaC produced specific immunofluorescence labeling of M-1 cells. Pretreatment with plasmin abolished labeling of M-1 cells in a prostasin-dependent way. We conclude that, at low concentrations, plasmin interacts with GPI-anchored prostasin, which leads to cleavage of the -subunit and activation of ENaC, while at higher concentrations, plasmin directly activates ENaC.</p>
]]></description>
<dc:creator><![CDATA[Svenningsen, P., Uhrenholt, T. R., Palarasah, Y., Skjodt, K., Jensen, B. L., Skott, O.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00321.2009</dc:identifier>
<dc:title><![CDATA[Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1741</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1733</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1742?rss=1">
<title><![CDATA[The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1742?rss=1</link>
<description><![CDATA[
<p>Knockout (KO) of IL-6 has been shown to attenuate ANG II hypertension, and mineralocorticoid receptors (MR) have been reported to contribute to the increase in IL-6 during acute ANG II infusion. This study determined whether that MR action is sustained with chronic ANG II infusion and whether it plays a role in mediating ANG II hypertension. ANG II infusion (90 ng/min) increased plasma IL-6 from 1.6 &plusmn; 0.6 to 22.7 &plusmn; 2.2 and 19.9 &plusmn; 3.2 pg/ml on <I>days 7</I> and <I>14</I>, respectively, and chronic MR blockade with spironolactone attenuated that only at <I>day 7</I> (7.2 &plusmn; 2.2 pg/ml). ANG II increased MAP (19 h/day with telemetry) ~40 mmHg, but in ANG II+spironolactone mice (25 or 50 mg&middot;kg<sup>&ndash;1</sup>&middot;day<sup>&ndash;1</sup>), mean arterial pressure (MAP) was not significantly different despite a tendency for lower pressure the first 6 days. To isolate further the mineralocorticoid link to IL-6 and blood pressure, DOCA-salt hypertension was induced in IL-6 KO and wild-type (WT) mice. Plasma IL-6 increased from 4.1 &plusmn; 1.7 to 34.5 &plusmn; 7.0 pg/ml by <I>day 7</I> of DOCA treatment in the WT mice but was back to control levels by <I>day 14</I>. An IL-6 bioassay using the murine B9, B-cell hybridoma cell line demonstrated that plasma IL-6 measurements reflected actual IL-6 bioactivity. The hypertension was not different and virtually superimposable in WT vs. IL-6 KO mice, averaging 145 &plusmn; 2 and 144 &plusmn; 3 mmHg, respectively. Both experiments confirm chronic stimulation of IL-6 by mineralocorticoids but show that it is transient. In addition, IL-6 was not required for mineralocorticoid hypertension. This suggests that aldosterone contributes to the increase in plasma IL-6 in the early stage of ANG II hypertension but that the blood pressure actions of IL-6 in that model are linked most likely to ANG II rather than aldosterone.</p>
]]></description>
<dc:creator><![CDATA[Sturgis, L. C., Cannon, J. G., Schreihofer, D. A., Brands, M. W.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90995.2008</dc:identifier>
<dc:title><![CDATA[The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1748</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1742</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1749?rss=1">
<title><![CDATA[Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1749?rss=1</link>
<description><![CDATA[
<p>Understanding the early factors affecting obesity development in males and females may help to prevent obesity and may lead to the discovery of more effective treatments for those already obese. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat model of obesity is characterized by hyperphagia-induced obesity, due to a spontaneous lack of CCK<SUB>1</SUB> receptors. In the present study, we focused on the behavioral and physiological aspects of obesity development from weaning to adulthood. We examined body weight, feeding efficiency, fat pad [brown, retroperitoneal, inguinal and epydidimal (in males)] weight, inguinal adipocyte size and number, leptin and oxytocin levels, body mass index, waist circumference, and females' estrous cycle structure. In the males, central hypothalamic gene expression was also examined. OLETF rats presented overall higher fat and leptin levels, larger adipocytes, and increased waist circumference and BMI from weaning until adulthood, compared with controls. Analysis of developmental patterns of gene expression for hypothalamic neuropeptides revealed peptide-specific patterns that may underlie or be a consequence of the obesity development. Analysis of the developmental trajectories toward obesity within the OLETF strain revealed that OLETF females developed obesity in a more gradual manner than the males, presenting delayed obesity-related "turning points," with reduced adipocyte size but larger postweaning fat pads and increased adipocyte hyperplasia compared with the males. Intake decrease in estrus vs. proestrus was significantly less in OLETF vs. Long-Evans Tokushima Otsuka females. The findings highlight the importance of using different sex-appropriate approaches to increase the efficacy of therapeutic interventions in the treatment and prevention of chronic early-onset obesity.</p>
]]></description>
<dc:creator><![CDATA[Schroeder, M., Zagoory-Sharon, O., Shbiro, L., Marco, A., Hyun, J., Moran, T. H., Bi, S., Weller, A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00461.2009</dc:identifier>
<dc:title><![CDATA[Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1760</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1749</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1761?rss=1">
<title><![CDATA[The effects of apelin treatment on skeletal muscle mitochondrial content]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1761?rss=1</link>
<description><![CDATA[
<p>Adipose tissue is recognized as a key player in the regulation of whole body metabolism. Apelin, is a recently identified adipokine that when given to mice results in increases in skeletal muscle uncoupling protein 3 (UCP3) content. Similarly, acute apelin treatment has been shown to increase the activity of 5'-AMP-activated protein kinase (AMPK), a reputed mediator of skeletal muscle mitochondrial biogenesis. Given these findings, we sought to determine the effects of apelin on skeletal muscle mitochondrial content. Male Wistar rats were given daily intraperitoneal injections of apelin-13 (100 nmol/kg) for 2 wk. We made the novel observation that the activities of citrate synthase, cytochrome <I>c</I> oxidase, and &beta;-hydroxyacyl coA dehydrogenase (&beta;HAD) were increased in triceps but not heart and soleus muscles from apelin-treated rats. When confirming these results we found that both nuclear and mitochondrial-encoded subunits of the respiratory chain were increased in triceps from apelin-treated rats. Similarly, apelin treatment increased the protein content of components of the mitochondrial import and assembly pathway. The increases in mitochondrial marker proteins were associated with increases in proliferator-activated receptor- coactivator-1 (PGC-1&beta;) but not PGC-1 or Pgc-1-related co-activator (PRC) mRNA expression. Chronic and acute apelin treatment did not increase the protein content and/or phosphorylation status of AMPK and its downstream substrate acetyl-CoA carboxylase. These findings are the first to demonstrate that apelin treatment can induce skeletal muscle mitochondrial content. Given the lack of an effect of apelin on AMPK signaling and PGC-1 mRNA expression, these results suggest that apelin increases skeletal muscle mitochondrial content through a mechanism that is distinct from that of more robust physiological stressors.</p>
]]></description>
<dc:creator><![CDATA[Frier, B. C., Williams, D. B., Wright, D. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00422.2009</dc:identifier>
<dc:title><![CDATA[The effects of apelin treatment on skeletal muscle mitochondrial content]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1768</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1761</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1769?rss=1">
<title><![CDATA[Glucose homeostasis is impaired by a paradoxical interaction between metformin and insulin in carnivorous rainbow trout]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1769?rss=1</link>
<description><![CDATA[
<p>Utilizing rainbow trout (<I>Oncorhynchus mykiss</I>) as a known model of a "glucose-intolerant" and poor dietary glucose user, we assessed glucose utilization in fish chronically receiving two molecules able to improve glucose homeostasis: insulin and metformin. Our objectives were to assess the ability of rainbow trout to deal with a glucose load and to improve glucose utilization in fish receiving a chronic administration of insulin plus metformin treatments. Fish received (implanted miniosmotic pumps) saline, insulin, metformin, and insulin plus metformin solution for 4 days and then were subjected to a glucose challenge (intraperitoneal injection) to study glucose homeostasis, analyzing plasma glycemia, mRNA levels of glucose metabolism-related proteins, insulin signaling, and glycogen levels in liver and muscle. Control fish received a saline pump implantation and saline intraperitoneal injection. We found no evidence that the "glucose intolerance" in this species could be linked to any of the molecular markers of metabolism in the tissues analyzed. By contrast, very interestingly, we show for the first time, that metformin is not only unable to improve glucose homeostasis in trout, but, in fact, its counteracts the effects of insulin, creating an "insulin resistance," especially in the muscle. These results make trout an attractive original model to study both insulin and metformin effect on biological systems.</p>
]]></description>
<dc:creator><![CDATA[Polakof, S., Skiba-Cassy, S., Panserat, S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00369.2009</dc:identifier>
<dc:title><![CDATA[Glucose homeostasis is impaired by a paradoxical interaction between metformin and insulin in carnivorous rainbow trout]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1776</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1769</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1777?rss=1">
<title><![CDATA[Effects of postural changes and removal of vestibular inputs on blood flow to and from the hindlimb of conscious felines]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1777?rss=1</link>
<description><![CDATA[
<p>Considerable data show that the vestibular system contributes to blood pressure regulation. Prior studies reported that lesions that eliminate inputs from the inner ears attenuate the vasoconstriction that ordinarily occurs in the hindlimbs of conscious cats during head-up rotations. These data led to the hypothesis that labyrinthine-deficient animals would experience considerable lower body blood pooling during head-up postural alterations. The present study tested this hypothesis by comparing blood flow though the femoral artery and vein of conscious cats during 20&ndash;60&deg; head-up tilts from the prone position before and after removal of vestibular inputs. In vestibular-intact animals, venous return from the hindlimb dropped considerably at the onset of head-up tilts and, at 5 s after the initiation of 60&deg; rotations, was 66% lower than when the animals were prone. However, after the animals were maintained in the head-up position for another 15 s, venous return was just 33% lower than before the tilt commenced. At the same time point, arterial inflow to the limb had decreased 32% from baseline, such that the decrease in blood flow out of the limb due to the force of gravity was precisely matched by a reduction in blood reaching the limb. After vestibular lesions, the decline in femoral artery blood flow that ordinarily occurs during head-up tilts was attenuated, such that more blood flowed into the leg. Contrary to expectations, in most animals, venous return was facilitated, such that no more blood accumulated in the hindlimb than when labyrinthine signals were present. These data show that peripheral blood pooling is unlikely to account for the fluctuations in blood pressure that can occur during postural changes of animals lacking inputs from the inner ear. Instead, alterations in total peripheral resistance following vestibular dysfunction could affect the regulation of blood pressure.</p>
]]></description>
<dc:creator><![CDATA[Yavorcik, K. J., Reighard, D. A., Misra, S. P., Cotter, L. A., Cass, S. P., Wilson, T. D., Yates, B. J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00551.2009</dc:identifier>
<dc:title><![CDATA[Effects of postural changes and removal of vestibular inputs on blood flow to and from the hindlimb of conscious felines]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1784</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1777</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1785?rss=1">
<title><![CDATA[Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1785?rss=1</link>
<description><![CDATA[
<p>Intrauterine growth retardation (IUGR) has been linked to the development of Type 2 diabetes in adulthood. We have developed an IUGR model in the rat whereby the animals develop diabetes later in life. Previous studies demonstrate that administration of the long-acting glucagon-like-peptide-1 agonist, Exendin-4, during the neonatal period prevents the development of diabetes in IUGR rats. IUGR animals exhibit hepatic insulin resistance early in life (prior to the onset of hyperglycemia), characterized by blunted suppression of hepatic glucose production (HGP) in response to insulin. Basal HGP is also significantly higher in IUGR rats. We hypothesized that neonatal administration of Exendin-4 would prevent the development of hepatic insulin resistance. IUGR and control rats were given Exendin-4 on <I>days 1&ndash;6</I> of life. Hyperinsulinemic-euglycemic clamp studies showed that Ex-4 significantly reduced basal HGP by 20% and normalized insulin suppression of HGP in IUGR rats. While Ex-4 decreased body weight and fat content in both Control and IUGR animals, these differences were only statistically significant in Controls. Exendin-4 prevented development of oxidative stress in liver and reversed insulin-signaling defects in vivo, thereby preventing the development of hepatic insulin resistance. Defects in glucose disposal and suppression of hepatic glucose production in response to insulin were reversed. Similar results were obtained in isolated Ex-4-treated neonatal hepatocytes. These results indicate that exposure to Exendin-4 in the newborn period reverses the adverse consequences of fetal programming and prevents the development of hepatic insulin resistance.</p>
]]></description>
<dc:creator><![CDATA[Raab, E. L., Vuguin, P. M., Stoffers, D. A., Simmons, R. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:39 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00519.2009</dc:identifier>
<dc:title><![CDATA[Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1794</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1785</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1795?rss=1">
<title><![CDATA[Metallothionein deficiency leads to soleus muscle contractile dysfunction following acute spinal cord injury in mice]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1795?rss=1</link>
<description><![CDATA[
<p>Metallothionein (MT) is a small molecular weight protein possessing metal binding and free radical scavenging properties. We hypothesized that MT-1/MT-2 null (MT<sup>&ndash;/&ndash;</sup>) mice would display exacerbated soleus muscle atrophy, oxidative injury, and contractile dysfunction compared with the response of wild-type (WT) mice following acute spinal cord transection (SCT). Four groups of mice were studied: WT laminectomy, WT transection, MT<sup>&ndash;/&ndash;</sup> laminectomy (MT<sup>&ndash;/&ndash;</sup> lami), and MT<sup>&ndash;/&ndash;</sup> transection (MT<sup>&ndash;/&ndash;</sup> trans). Laminectomy animals served as surgical controls. Mice in SCT groups experienced similar percent body mass (BM) losses at 7 days postinjury. Soleus muscle mass (MM) and MM-to-BM ratio were lower at 7 days postinjury in SCT vs. laminectomy mice, with no differences observed between strains. However, soleus muscles from MT<sup>&ndash;/&ndash;</sup> trans mice showed reduced maximal specific tension compared with MT<sup>&ndash;/&ndash;</sup> lami animals. Mean cross-sectional area (&micro;m<sup>2</sup>) of type I and type IIa fibers decreased similarly in SCT groups compared with laminectomy controls, and no difference in fiber distribution was observed. Lipid peroxidation (4-hydroxynoneal) was greater in MT<sup>&ndash;/&ndash;</sup> trans vs. MT<sup>&ndash;/&ndash;</sup> lami mice, but protein oxidation (protein carbonyls) was not altered by MT deficiency or SCT. Expression of key antioxidant proteins (catalase, manganese, and copper-zinc superoxide dismutase) was similar between the groups. In summary, MT deficiency did not impact soleus MM loss, but resulted in contractile dysfunction and increased lipid peroxidation following acute SCT. These findings suggest a role of MT in mediating protective adaptations in skeletal muscle following disuse mediated by spinal cord injury.</p>
]]></description>
<dc:creator><![CDATA[DeRuisseau, L. R., Recca, D. M., Mogle, J. A., Zoccolillo, M., DeRuisseau, K. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:40 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00263.2009</dc:identifier>
<dc:title><![CDATA[Metallothionein deficiency leads to soleus muscle contractile dysfunction following acute spinal cord injury in mice]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1802</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1795</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1803?rss=1">
<title><![CDATA[Expression of glucose-dependent insulinotropic polypeptide in the zebrafish]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1803?rss=1</link>
<description><![CDATA[
<p>In mammals, glucose-dependent insulinotropic polypeptide (GIP) is synthesized predominately in the small intestine and functions in conjunction with insulin to promote nutrient deposition. However, little is known regarding GIP expression and function in early vertebrates like the zebrafish, a model organism representing an early stage in the evolutionary development of the compound vertebrate pancreas. Analysis of GIP and insulin (<I>insa</I>) expression in zebrafish larvae by RT-PCR demonstrated that although <I>insa</I> was detected as early as 24 h postfertilization (hpf), GIP expression was not demonstrated until 72 hpf, shortly after the completion of endocrine pancreatic development but prior to the commencement of independent feeding. Furthermore, whole mount in situ hybridization of zebrafish larvae showed expression of GIP and <I>insa</I> in the same tissues, and in adult zebrafish, RT-PCR and immunohistochemistry demonstrated GIP expression in both the intestine and the pancreas. Receptor activation studies showed that zebrafish GIP was capable of activating the rat GIP receptor. Although previous studies have identified four receptors with glucagon receptor-like sequences in the zebrafish, one of which possesses the capacity to bind GIP, a functional analysis of these receptors has not been performed. This study demonstrates interactions between the latter receptor and zebrafish GIP, identifying it as a potential in vivo target for the ligand. Finally, food deprivation studies in larvae demonstrated an increase in GIP and proglucagon II mRNA levels in response to fasting. In conclusion, the results of these studies suggest that although the zebrafish appears to be a model of an early stage of evolutionary development of GIP expression, the peptide may not possess incretin properties in this species.</p>
]]></description>
<dc:creator><![CDATA[Musson, M. C., Jepeal, L. I., Mabray, P. D., Zhdanova, I. V., Cardoso, W. V., Wolfe, M. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:40 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00288.2009</dc:identifier>
<dc:title><![CDATA[Expression of glucose-dependent insulinotropic polypeptide in the zebrafish]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1812</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1803</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1813?rss=1">
<title><![CDATA[Site-specific attenuation of food intake but not the latency to eat after hypothalamic injections of neuropeptide Y in dehydrated-anorexic rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1813?rss=1</link>
<description><![CDATA[
<p>Anorexia that accompanies cellular dehydration in rats (DE-anorexia) offers a relatively simple model for investigating the functional organization of neural mechanisms that can suppress feeding during dehydration. Previous studies strongly suggest that the inputs that drive ingestive behavior control neurons in the paraventricular nucleus of the hypothalamus (PVH) and lateral hypothalamic area (LHA) remain active during DE-anorexia. Here we examine whether these two regions retain their sensitivity to neuropeptide Y (NPY). NPY is an important component in two major feeding-related inputs from the arcuate nucleus and the hindbrain. We found that intake responses to NPY injections in the LHA and PVH were suppressed in DE-anorexia, but the PVH remained less sensitive to the effects of NPY than the LHA in DE-anorexic animals. Indeed the higher dose of NPY (238 pmol) completely overcame shorter periods of DE-anorexia when injected into the LHA but not the PVH. However, the latency to eat after NPY injections remained unchanged from control animals, regardless of NPY dose, injection location, or intensity of anorexia. Furthermore, the onset and size of the strong and rapidly induced compensatory feeding that follows the return of water to DE-anorexic animals was also unaffected by any NPY injections. These data support the hypothesis that DE-anorexia develops as a consequence of the premature termination of regularly initiated meals, which perhaps involves processes that alter the sensitivity of satiety mechanisms downstream to the PVH and LHA.</p>
]]></description>
<dc:creator><![CDATA[Salter-Venzon, D., Watts, A. G.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:40 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00116.2009</dc:identifier>
<dc:title><![CDATA[Site-specific attenuation of food intake but not the latency to eat after hypothalamic injections of neuropeptide Y in dehydrated-anorexic rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1821</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1813</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1822?rss=1">
<title><![CDATA[Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/6/R1822?rss=1</link>
<description><![CDATA[
<p>Heme oxygenase (HO) is the enzyme responsible for the breakdown of heme-generating carbon monoxide (CO) and biliverdin in this process. HO-2 is the constitutively expressed isoform in most tissues, such as the kidney and vasculature. CO generated by HO is believed to be an important vasodilator in the renal circulation along with another gas, nitric oxide (NO). To determine the importance of HO-2 in the regulation of blood pressure and renal blood flow (RBF), we treated HO-2 knockout (KO) mice chronically with either ANG II or <I>N</I><sup>G</sup>-nitroarginine methyl ester (<scp>l</scp>-NAME). Basal blood pressures were not different between wild-type (WT), heterozygous (HET), or KO mice and averaged 113 &plusmn; 3 vs. 115 &plusmn; 2 vs. 116 &plusmn; 2 mmHg. Similar increases in blood pressure to chronic ANG II as well as <scp>l</scp>-NAME treatment were observed in all groups with blood pressures increasing an average of 30 mmHg in response to ANG II and 15 mmHg in response to <scp>l</scp>-NAME. Basal RBFs were not different between the groups averaging 6.0 &plusmn; 0.5 (<I>n</I> = 6) vs. 4.8 &plusmn; 0.6 (<I>n</I> = 10) vs. 5.8 &plusmn; 0.7 (<I>n</I> = 6) ml&middot;min<sup>&ndash;1</sup>&middot;g<sup>&ndash;1</sup> kidney weight in WT, HET, and KO mice. HO-2 KO and HET mice exhibited an attenuated decrease in RBF in response to acute administration of ANG II, while no differences were observed with <scp>l</scp>-NAME. Our data indicate that blood pressure and RBF responses to increased ANG II or inhibition of nitric oxide are not significantly enhanced in HO-2 KO mice.</p>
]]></description>
<dc:creator><![CDATA[Stec, D. E., Vera, T., Storm, M. V., McLemore, G. R., Ryan, M. J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 15:31:40 PST</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00319.2009</dc:identifier>
<dc:title><![CDATA[Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1828</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>R1822</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1215?rss=1">
<title><![CDATA[Age-dependent regression analysis of male gonadal axis]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1215?rss=1</link>
<description><![CDATA[
<p>The mechanisms by which aging progressively depletes testosterone (Te) availability in the male are unknown. Accordingly, the objective was to estimate brain gonadotropin-releasing hormone (GnRH) outflow (release and action), which cannot be observed directly, on the basis of downstream effects on pituitary luteinizing hormone (LH) secretion. LH, in turn, feeds forward on (stimulates) gonadal Te secretion, which then feeds back on (inhibits) GnRH-driven LH secretion. LH and Te concentrations were measured repetitively (every 10 min) over 18 h during graded pharmacological blockade of endogenous GnRH outflow in 24 healthy 20- to 72-yr-old men. Data were analyzed using a new age-dependent regression model of GnRH-LH-Te interactions to estimate pulsatile LH secretion and elimination, GnRH outflow, LH feedforward, and Te feedback. By incorporating regression on age within the dose-response model, we show that aging erodes all three primary forward and reverse pathways linking the brain, pituitary gland, and testes. Aging is associated with concomitant deficits in GnRH -&gt; LH feedforward, LH -&gt; Te feedforward, and Te -&gt; GnRH/LH feedback. The analytical formalism should be generalizable to other ensemble regulatory systems, such as those that control growth, reproduction, stress adaptations, and glucose metabolism.</p>
]]></description>
<dc:creator><![CDATA[Keenan, D. M., Veldhuis, J. D.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90800.2008</dc:identifier>
<dc:title><![CDATA[Age-dependent regression analysis of male gonadal axis]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1227</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1215</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1228?rss=1">
<title><![CDATA[Effects of contraction on localization of GLUT4 and v-SNARE isoforms in rat skeletal muscle]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1228?rss=1</link>
<description><![CDATA[
<p>In skeletal muscle, contractions increase glucose uptake due to a translocation of GLUT4 glucose transporters from intracellular storage sites to the surface membrane. Vesicle-associated membrane proteins (VAMPs) are believed to play an important role in docking and fusion of the GLUT4 transporters at the surface membrane. However, knowledge about which VAMP isoforms colocalize with GLUT4 vesicles in mature skeletal muscle and whether they translocate during muscle contractions is incomplete. The aim of the present study was to further identify VAMP isoforms, which are associated with GLUT4 vesicles and examine which VAMP isoforms translocate to surface membranes in skeletal muscles undergoing contractions. VAMP2, VAMP3, VAMP5, and VAMP7 were enriched in immunoprecipitated GLUT4 vesicles. In response to 20 min of in situ contractions, there was a redistribution of GLUT4 (+64 &plusmn; 13%), transferrin receptor (TfR; +75 &plusmn; 22%), and insulin-regulated aminopeptidase (IRAP; +70 &plusmn; 13%) to fractions enriched in heavy membranes away from low-density membranes (&ndash;32 &plusmn; 7%; &ndash;18 &plusmn; 12%; &ndash;33 &plusmn; 9%; respectively), when compared with the resting contralateral muscle. Similarly, there was a redistribution of VAMP2 (+240 &plusmn; 40%), VAMP5 (+79 &plusmn; 9%), and VAMP7 (+79 &plusmn; 29%), but not VAMP3, to fractions enriched in heavy membranes away from low-density membranes (&ndash;49 &plusmn; 10%, &ndash;54 &plusmn; 9%, &ndash;14 &plusmn; 11%, respectively) in contracted vs. resting muscle. In summary, VAMP2, VAMP3, VAMP5, and VAMP7 coimmunoprecipitate with intracellular GLUT4 vesicles in muscle, and VAMP2, VAMP5, VAMP7, but not VAMP3, translocate to the cell surface membranes similar to GLUT4, TfR, and IRAP in response to muscle contractions. These findings suggest that VAMP2, VAMP5, and VAMP7 may be involved in translocation of GLUT4 during muscle contractions.</p>
]]></description>
<dc:creator><![CDATA[Rose, A. J., Jeppesen, J., Kiens, B., Richter, E. A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00258.2009</dc:identifier>
<dc:title><![CDATA[Effects of contraction on localization of GLUT4 and v-SNARE isoforms in rat skeletal muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1237</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1228</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1238?rss=1">
<title><![CDATA[Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1238?rss=1</link>
<description><![CDATA[
<p>Leptin is thought to reduce food intake, in part, by increasing sensitivity to satiation signals, including CCK. Leptin action in both forebrain and hindbrain reduces food intake, and forebrain leptin action augments both the anorexic and neuronal activation responses to CCK. Here, we asked whether leptin signaling in hindbrain also enhances these responses to CCK. We found that food intake was strongly inhibited at 30 min after a combination of 4th-intracerebroventricular (4th-icv) leptin injection and intraperitoneal CCK administration, whereas neither hormone affected intake during this period when given alone. Leptin injections targeted directly at the dorsal vagal complex (DVC) similarly enhanced the anorexic response to intraperitoneal CCK. Intra-DVC leptin injection also robustly increased the number of neurons positive for phospho-STAT3 staining in the area surrounding the site of injection, confirming local leptin receptor activation. Conversely, the anorexic response to 4th-icv leptin was completely blocked by IP devazepide, a CCKA-R antagonist, suggesting that hindbrain leptin reduces intake via a mechanism requiring endogenous CCK signaling. We then asked whether hindbrain leptin treatment enhances the dorsomedial hindbrain, hypothalamus, or amygdala c-Fos responses to IP CCK. We found that, in contrast to the effects of forebrain leptin administration, 4th-icv leptin injection had no effect on CCK-induced c-Fos in any structures examined. We conclude that leptin signaling in either forebrain or hindbrain areas can enhance the response to satiation signals and that multiple distinct neural circuits likely contribute to this interaction.</p>
]]></description>
<dc:creator><![CDATA[Williams, D. L., Baskin, D. G., Schwartz, M. W.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00182.2009</dc:identifier>
<dc:title><![CDATA[Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1246</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1238</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1247?rss=1">
<title><![CDATA[Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1247?rss=1</link>
<description><![CDATA[
<p>Sepsis and septic shock are the chief cause of death in intensive care units, with mortality rates between 30 and 70%. In a large animal model of septic shock, we have demonstrated hypotension, increased cardiac output, and tachycardia, together with renal vasodilatation and renal failure. The changes in cardiac sympathetic nerve activity (CSNA) that may contribute to the tachycardia have not been investigated, and the changes in renal SNA (RSNA) that may mediate the changes in renal blood flow and function are unclear. We therefore recorded CSNA and RSNA during septic shock in conscious sheep. Septic shock was induced by administration of <I>Escherichia coli</I>, which caused a delayed hypotension and an immediate, biphasic increase in heart rate (HR) associated with similar changes in CSNA. After <I>E. coli</I>, RSNA decreased for over 3 h, followed by a sustained increase (180%), whereas renal blood flow progressively increased and remained elevated. There was an initial diuresis, followed by oliguria and decreased creatinine clearance. There were differential changes in the range of the arterial baroreflex curves; it was depressed for HR, increased for CSNA, and unchanged for RSNA. Our findings, recording CSNA for the first time in septic shock, suggest that the increase in SNA to the heart is not driven solely by unloading of baroreceptors and that the increase has an important role to increase HR and cardiac output. There was little correlation between the changes in RSNA and renal blood flow, suggesting that the renal vasodilatation was mediated mainly by other mechanisms.</p>
]]></description>
<dc:creator><![CDATA[Ramchandra, R., Wan, L., Hood, S. G., Frithiof, R., Bellomo, R., May, C. N.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00437.2009</dc:identifier>
<dc:title><![CDATA[Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1253</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1247</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1254?rss=1">
<title><![CDATA[Central overexpression of leptin antagonist reduces wheel running and underscores importance of endogenous leptin receptor activity in energy homeostasis]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1254?rss=1</link>
<description><![CDATA[
<p>We used recombinant adeno-associated virus (rAAV)-mediated gene delivery to overexpress a mutant of rat leptin yielding a protein that acts as a neutral leptin receptor antagonist. The long-term consequences of this overexpression on body weight homeostasis and physical activity, as assessed by voluntary wheel running (WR), were determined in F344 <FONT FACE="arial,helvetica">x</FONT> Brown Norway (BN) rats. Leptin antagonist overexpression was confirmed by examination of mRNA levels in the hypothalamus. Food consumption and body weight gain were exacerbated in the antagonist group during both chow and high-fat feeding periods over the 192-day experiment. In a second experiment, a lower dose of antagonist vector was used that resulted in no change in food consumption but still increased body weight. The degree of antagonist overexpression was sufficient to partially block signal transducer and activator of transcription 3 (STAT3) phosphorylation due to administration of an acute submaximal dose of leptin. Rats were provided free access to running wheels for 4 days during both the chow and high-fat feeding periods. With both antagonist doses and during both chow and high-fat feeding, WR was substantially less with antagonist overexpression. In contrast, when leptin was overexpressed in the hypothalamus, WR activity was increased by greater than twofold. At death, adiposity and serum leptin levels were greater in the antagonist group. These data indicate that submaximal central leptin receptor blockade promotes obesity and diminishes WR activity. These findings underscore the critical role of unrestrained leptin receptor activity in long-term energy homeostasis and suggest that even minor disruption of leptin receptor function can promote obesity.</p>
]]></description>
<dc:creator><![CDATA[Matheny, M., Zhang, Y., Shapiro, A., Tumer, N., Scarpace, P. J.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90449.2008</dc:identifier>
<dc:title><![CDATA[Central overexpression of leptin antagonist reduces wheel running and underscores importance of endogenous leptin receptor activity in energy homeostasis]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1261</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1254</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1262?rss=1">
<title><![CDATA[Cadmium affects metabolic responses to prolonged anoxia and reoxygenation in eastern oysters (Crassostrea virginica)]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1262?rss=1</link>
<description><![CDATA[
<p>Benthic marine organisms such as mollusks are often exposed to periodic oxygen deficiency (due to the tidal exposure and/or seasonal expansion of the oxygen-deficient dead zones) and pollution by metals [e.g., cadmium, (Cd)]. These stressors can strongly affect mollusks' survival; however, physiological mechanisms of their combined effects are not fully understood. We studied the effects of Cd exposure on metabolic responses to prolonged anoxia and subsequent recovery in anoxia-tolerant intertidal mollusks <I>Crassostrea virginica</I> (eastern oysters). Anoxia led to an onset of anaerobiosis indicated by accumulation of <scp>l</scp>-alanine, acetate, and succinate. Prolonged anoxia (for 6 days) caused a decline in the maximum activity of electron transport chain and ADP-stimulated (<I>state 3</I>) oxygen uptake by mitochondria (MO<SUB>2</SUB>), but no change in the resting (<I>state 4</I>) MO<SUB>2</SUB> of oyster mitochondria, along with a slight but significant reduction of mitochondrial respiratory control ratio. During reoxygenation, there was a significant overshoot of mitochondrial MO<SUB>2</SUB> (by up to 70% above the normoxic steady-state values) in control oysters. Mild mitochondrial uncoupling during prolonged shutdown in anoxic tissues and a subsequent strong stimulation of mitochondrial flux during recovery may help to rapidly restore redox status and protect against elevated reactive oxygen species formation in oysters. Exposure to Cd inhibits anaerobic metabolism, abolishes reoxygenation-induced stimulation of mitochondrial MO<SUB>2</SUB>, and leads to oxidative stress (indicated by accumulation of DNA lesions) and a loss of mitochondrial capacity during postanoxic recovery. This may result in increased sensitivity to intermittent hypoxia and anoxia in Cd-exposed mollusks and will have implications for their survival in polluted estuaries and coastal zones.</p>
]]></description>
<dc:creator><![CDATA[Kurochkin, I. O., Ivanina, A. V., Eilers, S., Downs, C. A., May, L. A., Sokolova, I. M.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00324.2009</dc:identifier>
<dc:title><![CDATA[Cadmium affects metabolic responses to prolonged anoxia and reoxygenation in eastern oysters (Crassostrea virginica)]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1272</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1262</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1273?rss=1">
<title><![CDATA[Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1273?rss=1</link>
<description><![CDATA[
<p>Gastric bypass surgery efficiently and lastingly reduces excess body weight and reverses type 2 diabetes in obese patients. Although increased energy expenditure may also play a role, decreased energy intake is thought to be the main reason for weight loss, but the mechanisms involved are poorly understood. Therefore, the aim of this study was to characterize the changes in ingestive behavior in a rat model of Roux-en-Y gastric bypass surgery (RYGB). Obese (24% body fat compared with 18% in chow-fed controls), male Sprague-Dawley rats maintained for 15 wk before and 4 mo after RYGB or sham-surgery on a two-choice low-fat/high-fat diet, were subjected to a series of tests assessing energy intake, meal patterning, and food choice. Although sham-operated rats gained an additional 100 g body wt during the postoperative period, RYGB rats lost ~100 g. Intake of a nutritionally complete and palatable liquid diet (Ensure) was significantly reduced by ~50% during the first 2 wk after RYGB compared with sham surgery. Decreased intake was the result of greatly reduced meal size with only partial compensation by meal frequency, and a corresponding increase in the satiety ratio. Similar results were obtained with solid food (regular or high-fat chow) 6 wk after surgery. In 12- to 24-h two-choice liquid or solid diet paradigms with nutritionally complete low- and high-fat diets, RYGB rats preferred the low-fat choice (solid) or showed decreased acceptance for the high-fat choice (liquid), whereas sham-operated rats preferred the high-fat choices. A separate group of rats offered chow only before surgery completely avoided the solid high-fat diet in a choice paradigm. The results confirm anecdotal reports of "nibbling" behavior and fat avoidance in RYGB patients and provide a basis for more mechanistic studies in this rat model.</p>
]]></description>
<dc:creator><![CDATA[Zheng, H., Shin, A. C., Lenard, N. R., Townsend, R. L., Patterson, L. M., Sigalet, D. L., Berthoud, H.-R.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00343.2009</dc:identifier>
<dc:title><![CDATA[Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1282</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1273</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1283?rss=1">
<title><![CDATA[Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness?]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1283?rss=1</link>
<description><![CDATA[
<p>This study examined whether hypoxia causes free radical-mediated disruption of the blood-brain barrier (BBB) and impaired cerebral oxidative metabolism and whether this has any bearing on neurological symptoms ascribed to acute mountain sickness (AMS). Ten men provided internal jugular vein and radial artery blood samples during normoxia and 9-h passive exposure to hypoxia (12.9% O<SUB>2</SUB>). Cerebral blood flow was determined by the Kety-Schmidt technique with net exchange calculated by the Fick principle. AMS and headache were determined with clinically validated questionnaires. Electron paramagnetic resonance spectroscopy and ozone-based chemiluminescence were employed for direct detection of spin-trapped free radicals and nitric oxide metabolites. Neuron-specific enolase (NSE), S100&beta;, and 3-nitrotyrosine (3-NT) were determined by ELISA. Hypoxia increased the arterio-jugular venous concentration difference (a-v<SUB>D</SUB>) and net cerebral output of lipid-derived alkoxyl-alkyl free radicals and lipid hydroperoxides (<I>P</I> &lt; 0.05 vs. normoxia) that correlated with the increase in AMS/headache scores (<I>r</I> = &ndash;0.50 to &ndash;0.90, <I>P</I> &lt; 0.05). This was associated with a reduction in a-v<SUB>D</SUB> and hence net cerebral uptake of plasma nitrite and increased cerebral output of 3-NT (<I>P</I> &lt; 0.05 vs. normoxia) that also correlated against AMS/headache scores (<I>r</I> = 0.74&ndash;0.87, <I>P</I> &lt; 0.05). In contrast, hypoxia did not alter the cerebral exchange of S100&beta; and both global cerebral oxidative metabolism (cerebral metabolic rate of oxygen) and neuronal integrity (NSE) were preserved (<I>P</I> &gt; 0.05 vs. normoxia). These findings indicate that hypoxia stimulates cerebral oxidative-nitrative stress, which has broader implications for other clinical models of human disease characterized by hypoxemia. This may prove a risk factor for AMS by a mechanism that appears independent of impaired BBB function and cerebral oxidative metabolism.</p>
]]></description>
<dc:creator><![CDATA[Bailey, D. M., Taudorf, S., Berg, R. M. G., Lundby, C., McEneny, J., Young, I. S., Evans, K. A., James, P. E., Shore, A., Hullin, D. A., McCord, J. M., Pedersen, B. K., Moller, K.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00366.2009</dc:identifier>
<dc:title><![CDATA[Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness?]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1292</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1283</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1293?rss=1">
<title><![CDATA[Role of hypoleptinemia during cold adaptation in Brandt's voles (Lasiopodomys brandtii)]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1293?rss=1</link>
<description><![CDATA[
<p>Brandt's voles <I>Lasiopodomys brandtii</I> exhibit large increases in nonshivering thermogenesis to cope with chronic cold exposure, resulting in compensatory hyperphagia and fat mobilization. These physiological events are accompanied by a remarkable reduction in serum leptin levels. However, the role of hypoleptinemia in cold adaptation in this species is still unknown. In the present study, we tested the hypothesis that hypoleptinemia contributes to increases in food intake and brown adipose tissue (BAT) thermogenesis by modifying hypothalamic neuropeptides in cold-exposed Brandt's voles. Adult male voles were transferred to 5&deg;C for 28 days. Accompanied by a decrease in serum leptin levels, hypothalamic agouti-related protein (AgRP) mRNA levels were significantly increased, but there were no changes in the long form of leptin receptor (Ob-Rb), suppressor of cytokine signaling 3 (SOCS3), neuropeptide Y (NPY) mRNA, proopiomelanocortin (POMC), and cocaine- and amphetamine-regulated peptide (CART) mRNA levels in the hypothalamus. When cold-exposed voles were returned to warm (23&deg;C) for 28 days, body mass, food intake, serum leptin, and AgRP mRNA were restored to control levels. Leptin administration in cold-exposed voles decreased food intake as well as hypothalamic AgRP mRNA levels. There were no significant effects of leptin administration on hypothalamic Ob-Rb, SOCS3, NPY, POMC, CART mRNA, and uncoupling protein 1 levels under cold conditions. These results suggest that hypoleptinemia partially contributes to cold-induced hyperphagia, which might involve the elevation of hypothalamic AgRP gene expression.</p>
]]></description>
<dc:creator><![CDATA[Tang, G.-B., Cui, J.-G., Wang, D.-H.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00185.2009</dc:identifier>
<dc:title><![CDATA[Role of hypoleptinemia during cold adaptation in Brandt's voles (Lasiopodomys brandtii)]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1301</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1293</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1302?rss=1">
<title><![CDATA[High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1302?rss=1</link>
<description><![CDATA[
<p>Intracerebroventricular insulin decreases food intake (FI)<I>.</I> The central bed nucleus of the amygdala (CeA), as other regions of the brain regulating feeding behavior, expresses insulin receptors. Our objectives were to show an insulin anorectic response in the amygdala, study the effect of high-fat diets on this response, and map the neural network activated by CeA insulin using c-Fos immunohistochemistry. Sprague-Dawley (SD) rats fitted with unilateral CeA cannulas were adapted to a low-fat (LFD) diet before they were fed a high-fat diet (HFD). Their feeding response to CeA saline or insulin (8 mU) was tested after 24 h, 72 h, or 7 days of being on a HFD. In a second experiment, SD rats were fed the HFD for 3, 7, or 49 days and were then refed with the LFD. They were tested for their insulin response before and after an HFD and every 3 days for the following weeks. Insulin tolerance tests were performed in a parallel group of rats. The CeA insulin stimulation c-Fos expression was studied to identify the distribution of activated neuronal populations. Feeding an HFD for 72 h or more induced a CeA, but not peripheral, insulin resistance, which was slowly reversed by LFD refeeding. The duration of HFD feeding determined the time frame for reversal of the insulin resistance. CeA insulin increased c-Fos in multiple brain regions, including the arcuate nucleus/paraventricular nucleus region of the hypothalamus. We conclude that the amygdala may be an important site for insulin regulation of food intake and may have a significant role in determining susceptibility to HFD-induced obesity.</p>
]]></description>
<dc:creator><![CDATA[Boghossian, S., Lemmon, K., Park, M., York, D. A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00252.2009</dc:identifier>
<dc:title><![CDATA[High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1311</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1302</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1312?rss=1">
<title><![CDATA[Intraventricular injection of antibodies to {beta}1-integrins generates pressure gradients in the brain favoring hydrocephalus development in rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1312?rss=1</link>
<description><![CDATA[
<p>In some tissues, the injection of antibodies to the &beta;<SUB>1</SUB>-integrins leads to a reduction in interstitial fluid pressure, indicating an active role for the extracellular matrix in tissue pressure regulation. If perturbations of the matrix occur in the periventricular area of the brain, a comparable lowering of interstitial pressures may induce transparenchymal pressure gradients favoring ventricular expansion. To examine this concept, we measured periventricular (parenchymal) and ventricular pressures with a servo-null micropipette system (2-&micro;m tip) in adult Wistar rats before and after anti-integrin antibodies or IgG/IgM isotype controls were injected into a lateral ventricle. In a second group, the animals were kept for 2 wk after similar injections and after euthanization, the brains were removed and assessed for hydrocephalus. In experiments in which antibodies to &beta;<SUB>1</SUB>-integrins (<I>n</I> = 10) but not isotype control IgG/IgM (<I>n</I> = 7) were injected, we observed a decline in periventricular pressures relative to the preinjection values. Under similar circumstances, ventricular pressures were elevated (<I>n</I> = 10) and were significantly greater than those in the periventricular interstitium. We estimated ventricular to periventricular pressure gradients of up to 4.3 cmH<SUB>2</SUB>O. In the chronic preparations, we observed enlarged ventricles in many of the animals that received injections of anti-integrin antibodies (21 of 29 animals; 72%) but not in any animal receiving the isotype controls. We conclude that modulation/disruption of &beta;<SUB>1</SUB>-integrin-matrix interactions in the brain generates pressure gradients favoring ventricular expansion, suggesting a novel mechanism for hydrocephalus development.</p>
]]></description>
<dc:creator><![CDATA[Nagra, G., Koh, L., Aubert, I., Kim, M., Johnston, M.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00307.2009</dc:identifier>
<dc:title><![CDATA[Intraventricular injection of antibodies to {beta}1-integrins generates pressure gradients in the brain favoring hydrocephalus development in rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1321</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1312</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1322?rss=1">
<title><![CDATA[Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1322?rss=1</link>
<description><![CDATA[
<p>Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that has anti-inflammatory and anticachectic actions. The aim of this work was to elucidate whether EPA administration is able to prevent an arthritis-induced decrease in body weight and muscle wasting in rats. Arthritis was induced by intradermal injection of Freund's adjuvant; 3 days later, nine rats received 1 g/kg EPA or coconut oil daily. All rats were killed 15 days after adjuvant injection. EPA administration decreased the external signs of arthritis and paw volume as well as liver TNF- mRNA. EPA did not modify arthritis-induced decrease in food intake or body weight gain. However, EPA treatment prevented arthritis-induced increase in muscle TNF- and atrogin-1, whereas it attenuated the decrease in gastrocnemius weight and the increase in MuRF1 mRNA. Arthritis not only decreased myogenic regulatory factors but also increased PCNA, MyoD, and myogenin mRNA in the gastrocnemius. Western blot analysis showed that changes in protein content followed the pattern seen with mRNA. In the control rats, EPA administration increased PCNA and MyoD mRNA and protein. In arthritic rats, EPA did not modify the stimulatory effect of arthritis on these myogenic regulatory factors. The results suggest that in experimental arthritis, in addition to its anti-inflammatory effect, EPA treatment attenuates muscle wasting by decreasing atrogin-1 and MuRF1 gene expression and increasing the transcription factors that regulate myogenesis.</p>
]]></description>
<dc:creator><![CDATA[Castillero, E., Martin, A. I., Lopez-Menduina, M., Villanua, M. A., Lopez-Calderon, A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00388.2009</dc:identifier>
<dc:title><![CDATA[Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1331</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1322</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1332?rss=1">
<title><![CDATA[Insulin-like growth factor-I and genetic effects on indexes of protein degradation in response to feed deprivation in rainbow trout (Oncorhynchus mykiss)]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1332?rss=1</link>
<description><![CDATA[
<p>This study determined the effect of genetic variation, feed deprivation, and insulin-like growth factor-I (IGF-I) on weight loss, plasma IGF-I and growth hormone, and indexes of protein degradation in eight full-sibling families of rainbow trout. After 2 wk of feed deprivation, fish treated with IGF-I lost 16% less (<I>P</I> &lt; 0.05) wet weight than untreated fish. Feed deprivation increased growth hormone (<I>P</I> &lt; 0.05) and decreased IGF-I (<I>P</I> &lt; 0.05), but hormone levels were not altered by IGF-I. Plasma 3-methylhistidine concentrations were not affected by IGF-I but were decreased after 2 wk (<I>P</I> &lt; 0.05) and increased after 4 wk (<I>P</I> &lt; 0.05) of feed deprivation. In white muscle, transcript abundance of genes in the ubiquitin-proteasome, lysosomal, and calpain- and caspase-dependent pathways were affected by feed deprivation (<I>P</I> &lt; 0.05). IGF-I prevented the feed deprivation-induced upregulation of MAFbx (F-box) and cathepsin transcripts and reduced abundance of proteasomal mRNAs (<I>P</I> &lt; 0.05), suggesting that reduction of protein degradation via these pathways may be partially responsible for the IGF-I-induced reduction of weight loss. Family variations in gene expression, IGF-I concentrations, and weight loss during fasting suggest genetic variation in the fasting response, with considerable impact on regulation of proteolytic pathways. These data indicate that nutrient availability, IGF-I, and genetic variation affect weight loss, in part through alterations of proteolytic pathways in rainbow trout, and that regulation of genes within these pathways is coordinated in a way that supports a similar physiological response.</p>
]]></description>
<dc:creator><![CDATA[Cleveland, B. M., Weber, G. M., Blemings, K. P., Silverstein, J. T.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00272.2009</dc:identifier>
<dc:title><![CDATA[Insulin-like growth factor-I and genetic effects on indexes of protein degradation in response to feed deprivation in rainbow trout (Oncorhynchus mykiss)]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1342</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1332</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1343?rss=1">
<title><![CDATA[Synchrotron imaging of the grasshopper tracheal system: morphological and physiological components of tracheal hypermetry]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1343?rss=1</link>
<description><![CDATA[
<p>As grasshoppers increase in size during ontogeny, they have mass specifically greater whole body tracheal and tidal volumes and ventilation than predicted by an isometric relationship with body mass and body volume. However, the morphological and physiological bases to this respiratory hypermetry are unknown. In this study, we use synchrotron imaging to demonstrate that tracheal hypermetry in developing grasshoppers (<I>Schistocerca americana</I>) is due to increases in air sacs and tracheae and occurs in all three body segments, providing evidence against the hypothesis that hypermetry is due to gaining flight ability. We also assessed the scaling of air sac structure and function by assessing volume changes of focal abdominal air sacs. Ventilatory frequencies increased in larger animals during hypoxia (5% O<SUB>2</SUB>) but did not scale in normoxia. For grasshoppers in normoxia, inflated and deflated air sac volumes and ventilation scaled hypermetrically. During hypoxia (5% O<SUB>2</SUB>), many grasshoppers compressed air sacs nearly completely regardless of body size, and air sac volumes scaled isometrically. Together, these results demonstrate that whole body tracheal hypermetry and enhanced ventilation in larger/older grasshoppers are primarily due to proportionally larger air sacs and higher ventilation frequencies in larger animals during hypoxia. Prior studies showed reduced whole body tracheal volumes and tidal volume in late-stage grasshoppers, suggesting that tissue growth compresses air sacs. In contrast, we found that inflated volumes, percent volume changes, and ventilation were identical in abdominal air sacs of late-stage fifth instar and early-stage animals, suggesting that decreasing volume of the tracheal system later in the instar occurs in other body regions that have harder exoskeleton.</p>
]]></description>
<dc:creator><![CDATA[Greenlee, K. J., Henry, J. R., Kirkton, S. D., Westneat, M. W., Fezzaa, K., Lee, W.-K., Harrison, J. F.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00231.2009</dc:identifier>
<dc:title><![CDATA[Synchrotron imaging of the grasshopper tracheal system: morphological and physiological components of tracheal hypermetry]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1350</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1343</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1351?rss=1">
<title><![CDATA[Effects of maternal genotype and diet on offspring glucose and fatty acid-sensing ventromedial hypothalamic nucleus neurons]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1351?rss=1</link>
<description><![CDATA[
<p>Maternal obesity accentuates offspring obesity in dams bred to develop diet-induced obesity (DIO) on a 31% fat, high-sucrose, high-energy (HE) diet but has no effect on offspring of diet-resistant (DR) dams. Also, only DIO dams become obese when they and DR dams are fed HE diet throughout gestation and lactation. We assessed glucose and oleic acid (OA) sensitivity of dissociated ventromedial hypothalamic nucleus (VMN) neurons from 3- to 4-wk old offspring of DIO and DR dams fed chow or HE diet using fura-2 calcium imaging to monitor intracellular calcium fluctuations as an index of neuronal activity. Offspring of DIO dams fed chow had ~2-fold more glucose-inhibited (GI) neurons than did DR offspring. This difference was eliminated in offspring of DIO dams fed HE diet. At 2.5 mM glucose, offspring of chow-fed DIO dams had more GI neurons that were either excited or inhibited by OA than did DR offspring. Maternal HE diet intake generally increased the percentage of neurons that were excited and decreased the percentage that were inhibited by OA in both DIO and DR offspring. However, this effect was more pronounced in DIO offspring. These data, as well as concentration-dependent differences in OA sensitivity, suggest that genotype, maternal obesity, and dietary content can all affect the sensitivity of offspring VMN neurons to glucose and long-chain fatty acids. Such altered sensitivities may underlie the propensity of DIO offspring to become obese when fed high-fat, high-sucrose diets.</p>
]]></description>
<dc:creator><![CDATA[Le Foll, C., Irani, B. G., Magnan, C., Dunn-Meynell, A., Levin, B. E.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00370.2009</dc:identifier>
<dc:title><![CDATA[Effects of maternal genotype and diet on offspring glucose and fatty acid-sensing ventromedial hypothalamic nucleus neurons]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1357</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1351</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1358?rss=1">
<title><![CDATA[Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1358?rss=1</link>
<description><![CDATA[
<p>The present studies evaluated intrarenal hemodynamics, pressure natriuresis, and arterial blood pressure in rats following recovery from renal ischemia-reperfusion (I/R) injury. Acute I/R injury, induced by 40 min of bilateral renal arterial occlusion, resulted in an increase in plasma creatinine that resolved within a week. Following 5 wk of recovery on a 0.4% NaCl diet, the pressure-natriuresis response was assessed in anesthetized rats in which the kidney was denervated and extrarenal hormones were administered intravenously. Increasing renal perfusion pressure (RPP) from 107 to 141 mmHg resulted in a fourfold increase in urine flow and sodium excretion in sham control rats. In comparison, pressure diuresis and natriuresis were significantly attenuated in post-I/R rats. In sham rats, glomerular filtration rate (GFR) averaged 1.6 &plusmn; 0.2 ml&middot;min<sup>&ndash;1</sup>&middot;g kidney weight<sup>&ndash;1</sup> and renal blood flow (RBF) averaged 7.8 &plusmn; 0.7 ml&middot;min<sup>&ndash;1</sup>&middot;g kidney weight<sup>&ndash;1</sup> at RPP of 129 mmHg. Renal cortical blood flow, measured by laser-Doppler flowmetry, was well autoregulated whereas medullary blood flow and renal interstitial hydrostatic pressure increased directly with elevated RPP in sham rats. In contrast, GFR and RBF were significantly reduced whereas medullary perfusion and interstitial pressure demonstrated an attenuated response to RPP in post-I/R rats. Further experiments demonstrated that conscious I/R rats develop hypertension when sodium intake is increased. The present data indicate that the pressure-natriuretic-diuretic response in I/R rats is blunted because of a decrease in GFR and RBF and the depressed pressure-dependent increase in medullary blood flow and interstitial pressure.</p>
]]></description>
<dc:creator><![CDATA[Pechman, K. R., De Miguel, C., Lund, H., Leonard, E. C., Basile, D. P., Mattson, D. L.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.91022.2008</dc:identifier>
<dc:title><![CDATA[Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1363</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1358</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1364?rss=1">
<title><![CDATA[Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1364?rss=1</link>
<description><![CDATA[
<p>Chronic heart failure (HF) is characterized by increased sympathetic drive. Enhanced angiotensin II (ANG II) activity may contribute to the increased sympathoexcitation under HF condition. The present study examined sympathoexcitation by <I>1</I>) the effects of ANG II in the paraventricular nucleus (PVN) on renal sympathetic nerve activity (RSNA), and <I>2</I>) the altered ANG II type 1 (AT<SUB>1</SUB>) receptor expression during HF. Left coronary artery ligation was used to induce HF. In the anesthetized Sprague-Dawley rats, microinjection of ANG II (0.05&ndash;1 nmol) into the PVN increased RSNA, mean arterial pressure (MAP), and heart rate (HR) in both sham-operated and HF rats. The responses of RSNA and HR were significantly enhanced in rats with HF compared with sham rats (RSNA: 64 &plusmn; 8% vs. 33 &plusmn; 4%, <I>P</I> &lt; 0.05). Microinjection of AT<SUB>1</SUB> receptor antagonist losartan into the PVN produced a decrease of RSNA, MAP, and HR in both sham and HF rats. The RSNA and HR responses to losartan in HF rats were significantly greater (RSNA: &ndash;25 &plusmn; 4% vs. &ndash;13 &plusmn; 1%, <I>P</I> &lt; 0.05). Using RT-PCR and Western blot analysis, we found that there were significant increases in the AT<SUB>1</SUB> receptor mRNA (186 &plusmn; 39%) and protein levels (88 &plusmn; 20%) in the PVN of rats with HF (<I>P</I> &lt; 0.05). The immunofluorescence of AT<SUB>1</SUB> receptors was significantly higher in the PVN of rats with HF. These data support the conclusion that an increased angiotensinergic activity on sympathetic regulation, due to the upregulation of ANG II AT<SUB>1</SUB> receptors within the PVN, may contribute to the elevated sympathoexcitation that is observed during HF.</p>
]]></description>
<dc:creator><![CDATA[Zheng, H., Li, Y.-F., Wang, W., Patel, K. P.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:06 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00149.2009</dc:identifier>
<dc:title><![CDATA[Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1374</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1364</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1375?rss=1">
<title><![CDATA[Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1375?rss=1</link>
<description><![CDATA[
<p>Anticancer agents, such as cisplatin, stimulate nausea, vomiting, and behaviors indicative of malaise. Rats and mice do not possess a vomiting response, and, therefore, in these species, the ingestion of kaolin clay (a pica response) has been used as an index of malaise. In the rat, cisplatin-induced kaolin intake is inhibited by antiemetic treatments. In addition, cisplatin activates vagal afferent fibers in the gut, and kaolin intake induced by cisplatin is largely dependent on an intact vagus. Nevertheless, little is known about the brain pathways controlling pica. We investigated the role of the lateral parabrachial nucleus (lPBN), a major visceral afferent link between the hindbrain and forebrain, in cisplatin-induced c-Fos expression and pica. Injection of cisplatin (6 mg/kg ip) produced c-Fos expression in the ventrolateral (external) lPBN, a region receiving viscerosensory input. In rats with bilateral ibotenic acid lPBN lesions, cisplatin treatment substantially increased kaolin intake compared with controls (~30 g vs. ~5 g, respectively, over 24 h). Food intake was reduced by cisplatin treatment and by apomorphine, an emetic agent that acts centrally. Unlike cisplatin, however, apomorphine stimulated kaolin intake to a similar degree in both the lesioned and control rats, suggesting that lPBN damage neither produces nonspecific effects nor enhances malaise in general. These data suggest that lPBN-lesioned animals not only demonstrate pica after cisplatin treatment, but, in fact, show an exaggerated response that is greatly in excess of any treatment known to produce kaolin intake in rats.</p>
]]></description>
<dc:creator><![CDATA[Horn, C. C., De Jonghe, B. C., Matyas, K., Norgren, R.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00284.2009</dc:identifier>
<dc:title><![CDATA[Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1382</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1375</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1383?rss=1">
<title><![CDATA[Time-dependent effects of short-term training on muscle metabolism during the early phase of exercise]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1383?rss=1</link>
<description><![CDATA[
<p>In this study, we investigated the hypothesis that the metabolic adaptations observed during steady-state exercise soon after the onset of training would be displayed during the nonsteady period of moderate exercise and would occur in the absence of increases in peak aerobic power (Vo<SUB>2peak</SUB>) and in muscle oxidative potential. Nine untrained males [age = 20.8 &plusmn; 0.70 (SE) yr] performed a cycle task at 62% Vo<SUB>2peak</SUB> before (Pre-T) and after (Post-T) training for 2 h/day for 5 days at task intensity. Tissue samples extracted from the vastus lateralis at 0 min (before exercise) and at 10, 60, and 180 s of exercise, indicated that at Pre-T, reductions (<I>P</I> &lt; 0.05) in phosphocreatine and increases (<I>P</I> &lt; 0.05) in creatine, inorganic phosphate, calculated free ADP, and free AMP occurred at 60 and 180 s but not at 10 s. At Post-T, the concentrations of all metabolites were blunted (<I>P</I> &lt; 0.05) at 60 s. Training also reduced (<I>P</I> &lt; 0.05) the increase in lactate and the lactate-to-pyruvate ratio observed during exercise at Pre-T. These adaptations occurred in the absence of change in Vo<SUB>2peak</SUB> (47.8 &plusmn; 1.7 vs. 49.2 &plusmn; 1.7 ml&middot;kg<sup>&ndash;1</sup>&middot;min<sup>&ndash;1</sup>) and in the activities (mol&middot;kg protein<sup>&ndash;1</sup>&middot;h<sup>&ndash;1</sup>) of succinic dehydrogenase (3.48 &plusmn; 0.21 vs. 3.77 &plusmn; 0.35) and citrate synthase (7.48 &plusmn; 0.61 vs. 8.52 &plusmn; 0.65) but not cytochrome oxidase (70.8 &plusmn; 5.1 vs. 79.6 &plusmn; 6.6 U/g protein; <I>P</I> &lt; 0.05). It is concluded that the tighter metabolic control observed following short-term training is initially expressed during the nonsteady state, probably as a result of increases in oxidative phosphorylation that is not dependent on changes in Vo<SUB>2peak</SUB> while the role of oxidative potential remains uncertain.</p>
]]></description>
<dc:creator><![CDATA[Green, H. J., Bombardier, E., Burnett, M. E., Smith, I. C., Tupling, S. M., Ranney, D. A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00203.2009</dc:identifier>
<dc:title><![CDATA[Time-dependent effects of short-term training on muscle metabolism during the early phase of exercise]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1391</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1383</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1392?rss=1">
<title><![CDATA[Effects and mechanisms of gastrointestinal electrical stimulation on slow waves: a systematic canine study]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1392?rss=1</link>
<description><![CDATA[
<p>The aims of this study were to determine optimal pacing parameters of electrical stimulation on different gut segments and to investigate effects and possible mechanisms of gastrointestinal electrical stimulation on gut slow waves. Twelve female hound-mix dogs were used in this study. A total of six pairs of electrodes were implanted on the stomach, duodenum, and ascending colon. Bilateral truncal vagotomy was performed in six of the dogs. One experiment was designed to study the effects of the pacing frequency on the entrainment of gut slow waves. Another experiment was designed to study the modulatory effects of the vagal and sympathetic pathways on gastrointestinal pacing. The frequency of slow waves was 4.88 &plusmn; 0.23 cpm (range, 4&ndash;6 cpm) in the stomach and 19.68 &plusmn; 0.31 cpm (range, 18&ndash;22 cpm) in the duodenum. There were no consistent or dominant frequencies of the slow waves in the colon. The optimal parameters to entrain slow waves were: frequency of 1.1 intrinsic frequency (IF; 10% higher than IF) and pulse width of 150&ndash;450 ms (mean, 320.0 &plusmn; 85.4 ms) for the stomach, and 1.1 IF and 10&ndash;20 ms for the small intestine. Electrical stimulation was not able to alter colon slow waves. The maximum entrainable frequency was 1.27 IF in the stomach and 1.21 IF in the duodenum. Gastrointestinal pacing was not blocked by vagotomy nor the application of an - or &beta;-adrenergic receptor antagonist; whereas the induction of gastric dysrhythmia with electrical stimulation was completely blocked by the application of the - or &beta;-adrenergic receptor antagonist. Gastrointestinal pacing is achievable in the stomach and small intestine but not the colon, and the maximal entrainable frequency of the gastric and small intestinal slow waves is about 20% higher than the IF. The entrainment of slow waves with gastrointestinal pacing is not modulated by the vagal or sympathetic pathways, suggesting a purely peripheral or muscle effect.</p>
]]></description>
<dc:creator><![CDATA[Sun, Y., Song, G.-Q., Yin, J., Lei, Y., Chen, J. D. Z.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00006.2009</dc:identifier>
<dc:title><![CDATA[Effects and mechanisms of gastrointestinal electrical stimulation on slow waves: a systematic canine study]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1399</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1392</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1400?rss=1">
<title><![CDATA[Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1400?rss=1</link>
<description><![CDATA[
<p>The raphe magnus (RM) participates in opioid analgesia and contains pain-modulatory neurons with respiration-related discharge. Here, we asked whether RM contributes to respiratory depression, the most prevalent lethal effect of opioids. To investigate whether opioidergic transmission in RM produces respiratory depression, we microinjected a mu-opioid receptor agonist, DAMGO, or morphine into the RM of awake rodents. In mice, opioid microinjection produced sustained decreases in respiratory rate (170 to 120 breaths/min), as well as heart rate (520 to 400 beats/min). Respiratory sinus arrhythmia, indicative of enhanced parasympathetic activity, was prevalent in mice receiving DAMGO microinjection. We performed similar experiments in rats but observed no changes in breathing rate or heart rate. Both rats and mice experienced significantly more episodes of bradypnea, indicative of impaired respiratory drive, after opioid microinjection. During spontaneous arousals, rats showed less tachycardia after opioid microinjection than before microinjection, suggestive of an attenuated sympathetic tone. Thus, activation of opioidergic signaling within RM produces effects beyond analgesia, including the unwanted destabilization of cardiorespiratory function. These adverse effects on homeostasis consequent to opioid microinjection imply a role for RM in regulating the balance of sympathetic and parasympathetic tone.</p>
]]></description>
<dc:creator><![CDATA[Hellman, K. M., Mendelson, S. J., Mendez-Duarte, M. A., Russell, J. L., Mason, P.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00140.2009</dc:identifier>
<dc:title><![CDATA[Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1408</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1400</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1409?rss=1">
<title><![CDATA[pH regulating transporters in neurons from various chemosensitive brainstem regions in neonatal rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1409?rss=1</link>
<description><![CDATA[
<p>We studied the membrane transporters that mediate intracellular pH (pH<SUB>i</SUB>) recovery from acidification in brainstem neurons from chemosensitive regions of neonatal rats. Individual neurons within brainstem slices from the retrotrapezoid nucleus (RTN), the nucleus tractus solitarii (NTS), and the locus coeruleus (LC) were studied using a pH-sensitive fluorescent dye and fluorescence imaging microscopy. The rate of pH<SUB>i</SUB> recovery from an NH<SUB>4</SUB>Cl-induced acidification was measured, and the effects of inhibitors of various pH-regulating transporters determined. Hypercapnia (15% CO<SUB>2</SUB>) resulted in a maintained acidification in neurons from all three regions. Recovery in RTN neurons was nearly entirely eliminated by amiloride, an inhibitor of Na<sup>+</sup>/H<sup>+</sup> exchange (NHE). Recovery in RTN neurons was blocked ~50% by inhibitors of isoform 1 of NHE (NHE-1) but very little by an inhibitor of NHE-3 or by DIDS (an inhibitor of HCO<SUB>3</SUB>-dependent transport). In NTS neurons, amiloride blocked over 80% of the recovery, which was also blocked ~65% by inhibitors of NHE-1 and 26% blocked by an inhibitor of NHE-3. Recovery in LC neurons, in contrast, was unaffected by amiloride or blockers of NHE isoforms but was dependent on Na<sup>+</sup> and increased by external HCO<SUB>3</SUB><sup>&ndash;</sup>. On the basis of these findings, pH<SUB>i</SUB> recovery from acidification appears to be largely mediated by NHE-1 in RTN neurons, by NHE-1 and NHE-3 in NTS neurons, and by a Na- and HCO<SUB>3</SUB>-dependent transporter in LC neurons. Thus, pH<SUB>i</SUB> recovery is mediated by different pH-regulating transporters in neurons from different chemosensitive regions, but recovery is suppressed by hypercapnia in all of the neurons.</p>
]]></description>
<dc:creator><![CDATA[Kersh, A. E., Hartzler, L. K., Havlin, K., Hubbell, B. B., Nanagas, V., Kalra, A., Chua, J., Whitesell, R., Ritucci, N. A., Dean, J. B., Putnam, R. W.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.91038.2008</dc:identifier>
<dc:title><![CDATA[pH regulating transporters in neurons from various chemosensitive brainstem regions in neonatal rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1420</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1409</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1421?rss=1">
<title><![CDATA[Rainbow trout genetically selected for greater muscle fat content display increased activation of liver TOR signaling and lipogenic gene expression]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1421?rss=1</link>
<description><![CDATA[
<p>Genetic selection is commonly used in farm animals to manage body fat content. In rainbow trout, divergent selection for low or high muscle fat content leads to differences in utilization of dietary energy sources between the fat muscle line (FL) and the lean muscle line (LL). To establish whether genetic selection on muscle fat content affects the hepatic insulin/nutrient signaling pathway, we analyzed this pathway and the expression of several metabolism-related target genes in the livers of the two divergent lines under fasting and then refeeding conditions. Whereas glycemia returned to basal level 24 h after refeeding in FL trout, it remained elevated in the LL trout. Target of rapamycin (TOR) protein was more abundant in the livers of FL trout than in LL trout, and refeeding activation of the hepatic TOR signaling pathway (TOR, S6K1, and S6) was therefore enhanced. Genes related to glycolysis (glucokinase and pyruvate kinase) and gluconeogenesis (glucose-6-phosphatase and phosphoenolpyruvate carboxykinase) were only slightly affected by refeeding and genetic selection. Refeeding stimulated expression of lipogenic genes and the sterol-responsive element binding protein (SREBP1), and expression of fatty acid synthase, glucose-6-phosphate dehydrogenase, and serine dehydratase was predominant in the livers of FL fish compared with LL fish. In agreement with recent findings linking TOR to lipogenesis control, we concluded that genetic selection for muscle fat content resulted in overactivation of the TOR signaling pathway-associated lipogenesis and probably also improved utilization of glucose.</p>
]]></description>
<dc:creator><![CDATA[Skiba-Cassy, S., Lansard, M., Panserat, S., Medale, F.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00312.2009</dc:identifier>
<dc:title><![CDATA[Rainbow trout genetically selected for greater muscle fat content display increased activation of liver TOR signaling and lipogenic gene expression]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1429</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1421</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1430?rss=1">
<title><![CDATA[Recurrent restriction of sleep and inadequate recuperation induce both adaptive changes and pathological outcomes]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1430?rss=1</link>
<description><![CDATA[
<p>Chronic restriction of a basic biological need induces adaptations to help meet requisites for survival. The adaptations to chronic restriction of sleep are unknown. A single episode of 10 days of partial sleep loss in rats previously was shown to be tolerated and to result in increased food intake and loss of body weight as principal signs. The purpose of the present experiment was to investigate the extent to which adaptation to chronic sleep restriction would ameliorate short-term effects and result in a changed internal phenotype. Rats were studied during 10 wk of multiple periods of restricted and unrestricted sleep to allow adaptive changes to develop. Control rats received the same ambulatory requirements only consolidated into periods that lessened interruptions of their sleep. The results indicate a latent period of relatively stable food and water intake without weight gain, followed by a dynamic phase marked by enormous increases in food and water intake and progressive loss of body weight, without malabsorption of calories. Severe consequences ensued, marked especially by changes to the connective tissues, and became fatal for two individuals. The most striking changes to internal organs in sleep-restricted rats included lengthening of the small intestine, decreased size of adipocytes, and increased incidence of multilocular adipocytes. Major organs accounted for an increased proportion of total body mass. These changes to internal tissues appear adaptive in response to high energy production, decomposition of lipids, and increased need to absorb nutrients, but ultimately insufficient to compensate for inadequate sleep.</p>
]]></description>
<dc:creator><![CDATA[Everson, C. A., Szabo, A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00230.2009</dc:identifier>
<dc:title><![CDATA[Recurrent restriction of sleep and inadequate recuperation induce both adaptive changes and pathological outcomes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1440</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1430</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1441?rss=1">
<title><![CDATA[Effect of consecutive repeated sprint and resistance exercise bouts on acute adaptive responses in human skeletal muscle]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1441?rss=1</link>
<description><![CDATA[
<p>We examined acute molecular responses in skeletal muscle to repeated sprint and resistance exercise bouts. Six men [age, 24.7 &plusmn; 6.3 yr; body mass, 81.6 &plusmn; 7.3 kg; peak oxygen uptake, 47 &plusmn; 9.9 ml&middot;kg<sup>&ndash;1</sup>&middot;min<sup>&ndash;1</sup>; one repetition maximum (1-RM) leg extension 92.2 &plusmn; 12.5 kg; means &plusmn; SD] were randomly assigned to trials consisting of either resistance exercise (8 <FONT FACE="arial,helvetica">x</FONT> 5 leg extension, 80% 1-RM) followed by repeated sprints (10 <FONT FACE="arial,helvetica">x</FONT> 6 s, 0.75 N&middot;m torque&middot;kg<sup>&ndash;1</sup>) or vice-versa. Muscle biopsies from vastus lateralis were obtained at rest, 15 min after each exercise bout, and following 3-h recovery to determine early signaling and mRNA responses. There was divergent exercise order-dependent phosphorylation of p70 S6K (S6K). Specifically, initial resistance exercise increased S6K phosphorylation (~75% <I>P</I> &lt; 0.05), but there was no effect when resistance exercise was undertaken after sprints. Exercise decreased IGF-I mRNA following 3-h recovery (~50%, <I>P</I> = 0.06) independent of order, while muscle RING finger mRNA was elevated with a moderate exercise order effect (<I>P</I> &lt; 0.01). When resistance exercise was followed by repeated sprints PGC-1 mRNA was increased (REX1-SPR2; <I>P</I> = 0.02) with a modest distinction between exercise orders. Repeated sprints may promote acute interference on resistance exercise responses by attenuating translation initiation signaling and exacerbating ubiquitin ligase expression. Indeed, repeated sprints appear to generate the overriding acute exercise-induced response when undertaking concurrent repeated sprint and resistance exercise. Accordingly, we suggest that sprint-activities are isolated from resistance training and that adequate recovery time is considered within periodized training plans that incorporate these divergent exercise modes.</p>
]]></description>
<dc:creator><![CDATA[Coffey, V. G., Jemiolo, B., Edge, J., Garnham, A. P., Trappe, S. W., Hawley, J. A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00351.2009</dc:identifier>
<dc:title><![CDATA[Effect of consecutive repeated sprint and resistance exercise bouts on acute adaptive responses in human skeletal muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1451</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1441</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1452?rss=1">
<title><![CDATA[Aerobic exercise training improves whole muscle and single myofiber size and function in older women]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1452?rss=1</link>
<description><![CDATA[
<p>To comprehensively assess the influence of aerobic training on muscle size and function, we examined seven older women (71 &plusmn; 2 yr) before and after 12 wk of cycle ergometer training. The training program increased (<I>P</I> &lt; 0.05) aerobic capacity by 30 &plusmn; 6%. Quadriceps muscle volume, determined by magnetic resonance imaging (MRI), was 12 &plusmn; 2% greater (<I>P</I> &lt; 0.05) after training and knee extensor power increased 55 &plusmn; 7% (<I>P</I> &lt; 0.05). Muscle biopsies were obtained from the vastus lateralis to determine size and contractile properties of individual slow (MHC I) and fast (MHC IIa) myofibers, myosin light chain (MLC) composition, and muscle protein concentration. Aerobic training increased (<I>P</I> &lt; 0.05) MHC I fiber size 16 &plusmn; 5%, while MHC IIa fiber size was unchanged. MHC I peak power was elevated 21 &plusmn; 8% (<I>P</I> &lt; 0.05) after training, while MHC IIa peak power was unaltered. Peak force (Po) was unchanged in both fiber types, while normalized force (Po/cross-sectional area) was 10% lower (<I>P</I> &lt; 0.05) for both MHC I and MHC IIa fibers after training. The decrease in normalized force was likely related to a reduction (<I>P</I> &lt; 0.05) in myofibrillar protein concentration after training. In the absence of an increase in Po, the increase in MHC I peak power was mediated through an increased (<I>P</I> &lt; 0.05) maximum contraction velocity (Vo) of MHC I fibers only. The relative proportion of MLC<SUB>1s</SUB> (Pre: 0.62 &plusmn; 0.01; Post: 0.58 &plusmn; 0.01) was lower (<I>P</I> &lt; 0.05) in MHC I myofibers after training, while no differences were present for MLC<SUB>2s</SUB> and MLC<SUB>3f</SUB> isoforms. These data indicate that aerobic exercise training improves muscle function through remodeling the contractile properties at the myofiber level, in addition to pronounced muscle hypertrophy. Progressive aerobic exercise training should be considered a viable exercise modality to combat sarcopenia in the elderly population.</p>
]]></description>
<dc:creator><![CDATA[Harber, M. P., Konopka, A. R., Douglass, M. D., Minchev, K., Kaminsky, L. A., Trappe, T. A., Trappe, S.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00354.2009</dc:identifier>
<dc:title><![CDATA[Aerobic exercise training improves whole muscle and single myofiber size and function in older women]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1459</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1452</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1460?rss=1">
<title><![CDATA[Thermogenic activity of the Ca2+-ATPase from blue marlin heater organ: regulation by KCl and temperature]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1460?rss=1</link>
<description><![CDATA[
<p>This work shows that vesicles derived from the blue marlin heater organ retain a sarcoplasmic reticulum (SR) Ca<sup>2+</sup>-ATPase that can interconvert different forms of energy. During the hydrolysis of ATP part of the energy is always converted into heat, and the other part can be converted into work (Ca<sup>2+</sup> transport) or heat, depending on the temperature and the presence of KCl in the reaction medium. At 15&deg;C, where KCl stimulates the activity approximately threefold, measurements of the amount of heat released per mole of ATP hydrolyzed (H<sup>cal</sup>) show similar values (approximately &ndash;11 kcal/mol) in the presence or absence of a Ca<sup>2+</sup> gradient. At 25&deg;C, KCl activates the enzyme to the same extent as at 15&deg;C, but inhibits the production of extra heat by SR Ca<sup>2+</sup>-ATPase when a Ca<sup>2+</sup> gradient is built up across the membrane. The H<sup>cal</sup> values found in the presence of a Ca<sup>2+</sup>-gradient were &ndash;26.2 &plusmn; 2.9 kcal/mol (<I>n</I> = 7) in control experiments and &ndash;16.1 &plusmn; 1.5 (<I>n</I> = 14) in the presence of 100 mM KCl. At 35&deg;C, KCl has a smaller effect (~1.5-fold) on activating the enzyme. Similar to SR Ca<sup>2+</sup>-ATPase from mammals, at this temperature the enzyme produces almost twice the amount of heat per mole of ATP hydrolyzed in the presence of a Ca<sup>2+</sup> gradient and KCl has no effect at all on this increment. These data suggest that the marlin SR Ca<sup>2+</sup>-ATPase may play an important role in heater organ thermogenesis and that KCl has the potential for regulating the heat production catalyzed by the enzyme.</p>
]]></description>
<dc:creator><![CDATA[da Costa, D. C. F., Landeira-Fernandez, A. M.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90993.2008</dc:identifier>
<dc:title><![CDATA[Thermogenic activity of the Ca2+-ATPase from blue marlin heater organ: regulation by KCl and temperature]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1468</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1460</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1469?rss=1">
<title><![CDATA[Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1469?rss=1</link>
<description><![CDATA[
<p>Renin release from the juxtaglomerular (JG) cell is stimulated by the second messenger cAMP and inhibited by calcium. We previously showed JG cells contain a calcium sensing receptor (CaSR), which, when stimulated, decreases cAMP formation and inhibits renin release. We hypothesize CaSR activation decreases cAMP and renin release, in part, by stimulating a calcium calmodulin-activated phosphodiesterase 1 (PDE1). We incubated our primary culture of JG cells with two selective PDE1 inhibitors [8-methoxymethil-IBMX (8-MM-IBMX; 20 &micro;M) and vinpocetine (40 &micro;M)] and the calmodulin inhibitor W-7 (10 &micro;M) and measured cAMP and renin release. Stimulation of the JG cell CaSR with the calcimimetic cinacalcet (1 &micro;M) resulted in decreased cAMP from a basal of 1.13 &plusmn; 0.14 to 0.69 &plusmn; 0.08 pM/mg protein (<I>P</I> &lt; 0.001) and in renin release from 0.89 &plusmn; 0.16 to 0.38 &plusmn; 0.08 &micro;g ANG I/ml&middot;h<sup>&ndash;1</sup>&middot;mg protein<sup>&ndash;1</sup> (<I>P</I> &lt; 0.001). However, the addition of 8-MM-IBMX with cinacalcet returned both cAMP (1.10 &plusmn; 0.19 pM/mg protein) and renin (0.57 &plusmn; 0.16 &micro;g ANG I/ml&middot;h<sup>&ndash;1</sup>&middot;mg protein<sup>&ndash;1</sup>) to basal levels. Similar results were obtained with vinpocetine, and also with W-7. Combining 8-MM-IBMX and W-7 had no additive effect. To determine which PDE1 isoform is involved, we performed Western blot analysis for PDE1A, B, and C. Only Western blot analysis for PDE1C showed a characteristic band apparent at 80 kDa. Immunofluorescence showed cytoplasmic distribution of PDE1C and renin in the JG cells. In conclusion, PDE1C is expressed in isolated JG cells, and contributes to calcium's inhibitory modulation of renin release from JG cells.</p>
]]></description>
<dc:creator><![CDATA[Ortiz-Capisano, M. C., Liao, T.-D., Ortiz, P. A., Beierwaltes, W. H.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00121.2009</dc:identifier>
<dc:title><![CDATA[Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1476</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1469</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1477?rss=1">
<title><![CDATA[Maternal hemoglobin level and fetal outcome at low and high altitudes]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1477?rss=1</link>
<description><![CDATA[
<p>Both, low (&lt;7 g/dl) and high (&gt;14.5 g/dl), maternal hemoglobin (Hb) levels have been related to poor fetal outcome. Most studies have been done at low altitude (LA). Here, we have sought to determine whether this relationship exists at both high and low altitude, and also whether there is an adverse effect of high altitude (HA) on fetal outcome independent of level of maternal hemoglobin. The study is based on a retrospective multicenter analysis of 35,449 pregnancies at LA and six other cities above 3000 meters. In analyses of all women at both LA and HA, those with Hb &lt;9 g/dl had odds ratios (ORs) and 95% confidence intervals (CI) of 4.4 (CI: 2.8&ndash;6.7), 2.5 (CI: 1.9&ndash;3.2), and 1.4 (CI: 1.1&ndash;1.9) for stillbirths, preterm, and small for gestational age (SGA) births, respectively, compared with women with 11&ndash;12.9 g/dl of Hb, after adjustment for confounders. These risks by hemoglobin level differed little between women at LA and HA, suggesting that no correction of the definition of anemia is necessary for women at HA. Women living at high altitude with hemoglobin &gt;15.5 g/dl had higher risks for stillbirths (OR: 1.3; CI: 1.05&ndash;1.3), preterm (OR: 1.5; CI 1.3&ndash;1.8), and SGA births (OR: 2.1, CI 1.8&ndash;2.3). There was also a significant adverse effect of living at HA, independent of hemoglobin level for all three outcomes (OR: 3.9, 1.7, and 2.3; CI: 2.8&ndash;5.2, 1.5&ndash;1.9, and 2.1&ndash;2.5) for stillbirths, preterms, and SGA respectively, after adjusting for hemoglobin level. Both, high and low maternal hemoglobin levels were related to poor pregnancy outcome, with similar effect of low hemoglobin in both LA and HA. Our data suggest, that maternal hemoglobin above 11 g/dl but below 13 g/dl is the area of minimal risk of poor adverse outcomes. Living at HA had an adverse effect independent of hemoglobin level.</p>
]]></description>
<dc:creator><![CDATA[Gonzales, G. F., Steenland, K., Tapia, V.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00275.2009</dc:identifier>
<dc:title><![CDATA[Maternal hemoglobin level and fetal outcome at low and high altitudes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1485</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1477</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1486?rss=1">
<title><![CDATA[Functional significance of muscarinic receptor expression within the proximal and distal rat vagina]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1486?rss=1</link>
<description><![CDATA[
<p>Information regarding the role of cholinergic nerves in mediating vaginal smooth muscle contraction is sparse, and in vitro studies of the effects of muscarinic agonists on vaginal smooth muscle are discrepant. The goal of this study was to determine the expression of muscarinic receptors in the vaginal wall of the rat. In addition, we sought to determine the effect of the muscarinic receptor agonist carbachol on contractility and inositol phosphate production of the proximal and distal rat vaginal muscularis. RT-PCR analysis indicated that both M<SUB>2</SUB> and M<SUB>3</SUB> receptor transcripts were expressed within the proximal and distal rat vagina. Carbachol dose-dependently (10<sup>&ndash;7</sup>&ndash;10<sup>&ndash;4</sup> M) contracted the rat vaginal muscularis with a greater maximal contractile response in the proximal vagina (<I>P</I> &lt; 0.01) compared with the distal vagina. The contractile responses of the rat vaginal muscularis to carbachol were dose dependently inhibited by the M<SUB>3</SUB> antagonist para-fluoro-hexahydrosiladefenidol, and a pK<SUB>B</SUB> of 7.78 and 7.95 was calculated for the proximal and distal vagina, respectively. Inositol phosphate production was significantly increased in both regions of the vagina following 20-min exposure to 50 &micro;M carbachol with higher levels detected in the proximal vagina compared with the distal (<I>P</I> &lt; 0.05). Preliminary experiments indicated the presence of M<SUB>2</SUB> and M<SUB>3</SUB> receptors in the human vaginal muscularis as well as contraction of human vaginal muscularis to carbachol, indicating that our animal studies are relevant to human tissue. Our results provide strong evidence for the functional significance of M<SUB>3</SUB> receptor expression in the vaginal muscularis.</p>
]]></description>
<dc:creator><![CDATA[Basha, M., LaBelle, E. F., Northington, G. M., Wang, T., Wein, A. J., Chacko, S.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90516.2008</dc:identifier>
<dc:title><![CDATA[Functional significance of muscarinic receptor expression within the proximal and distal rat vagina]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1493</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1486</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1494?rss=1">
<title><![CDATA[Mice lacking the G protein {gamma}3-subunit show resistance to opioids and diet induced obesity]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1494?rss=1</link>
<description><![CDATA[
<p>Contributing to the obesity epidemic, there is increasing evidence that overconsumption of high-fat foods may be analogous to drug addiction in that the palatability of these foods is associated with activation of specific reward pathways in the brain. With this perspective, we report that mice lacking the G protein <SUB>3</SUB>-subunit (<I>Gng3</I><sup>&ndash;/&ndash;</sup> mice) show resistance to high-fat diet-induced weight gain over the course of a 12-wk study. Compared with <I>Gng3</I><sup>+/+</sup> controls, female <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice exhibit a 40% reduction in weight gain and a 53% decrease in fat pad mass, whereas male <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice display an 18% reduction in weight gain and no significant decrease in fat pad mass. The basis for the lowered weight gain is related to reduced food consumption for female and male <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice of 13% and 14%, respectively. Female <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice also show a lesser preference for high-fat chow than their female <I>Gng3</I><sup>+/+</sup> littermates, suggesting an attenuated effect on a reward pathway associated with overconsumption of fat. One possible candidate is the &micro;-opioid receptor (<I>Oprm1</I>) signaling cascade. Supporting a defect in this signaling pathway, <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice show marked reductions in both acute and chronic morphine responsiveness, as well as increases in endogenous opioid mRNA levels in reward-related regions of the brain. Taken together, these data suggest that the decreased weight gain of <I>Gng3</I><sup>&ndash;/&ndash;</sup> mice may be related to a reduced rewarding effect of the high-fat diet resulting from a defect in <I>Oprm1</I> signaling and loss of the G protein <SUB>3</SUB>-subunit.</p>
]]></description>
<dc:creator><![CDATA[Schwindinger, W. F., Borrell, B. M., Waldman, L. C., Robishaw, J. D.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00308.2009</dc:identifier>
<dc:title><![CDATA[Mice lacking the G protein {gamma}3-subunit show resistance to opioids and diet induced obesity]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1502</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1494</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1503?rss=1">
<title><![CDATA[Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1503?rss=1</link>
<description><![CDATA[
<p>Skeletal muscle produces a myriad of mitogenic factors possessing cardiovascular regulatory effects that can be explored for cardiac repair. Given the reported findings that VEGF may modulate muscle regeneration, we investigated the therapeutic effects of chronic injections of low doses of human recombinant VEGF-A<SUB>165</SUB> (0.1&ndash;1 &micro;g/kg) into the dystrophic hamstring muscle in a hereditary hamster model of heart failure and muscular dystrophy. In vitro, VEGF stimulated proliferation, migration, and growth factor production of cultured C2C12 skeletal myocytes. VEGF also induced production of HGF, IGF2, and VEGF by skeletal muscle. Analysis of skeletal muscle revealed an increase in myocyte nuclear [531 &plusmn; 12 VEGF 1 &micro;g/kg vs. 364 &plusmn; 19 for saline (number/mm<sup>2</sup>) saline] and capillary [591 &plusmn; 80 VEGF 1 &micro;g/kg vs. 342 &plusmn; 21 for saline (number/mm<sup>2</sup>)] densities. Skeletal muscle analysis revealed an increase in Ki67<sup>+</sup> nuclei in the VEGF 1 &micro;g/kg group compared with saline. In addition, VEGF mobilized c-kit<sup>+</sup>, CD31<sup>+</sup>, and CXCR4<sup>+</sup> progenitor cells. Mobilization of progenitor cells was consistent with higher SDF-1 concentrations found in hamstring, plasma, and heart in the VEGF group. Echocardiogram analysis demonstrated improvement in left ventricular ejection fraction (0.60 &plusmn; 0.02 VEGF 1 &micro;g/kg vs. 0.45 &plusmn; 0.01 mm for saline) and an attenuation in ventricular dilation [5.59 &plusmn; 0.12 VEGF 1 &micro;g/kg vs. 6.03 &plusmn; 0.09 for saline (mm)] 5 wk after initiating therapy. Hearts exhibited higher cardiomyocyte nuclear [845 &plusmn; 22 VEGF 1 &micro;g/kg vs. 519 &plusmn; 40 for saline (number/mm<sup>2</sup>)] and capillary [2,159 &plusmn; 119 VEGF 1 &micro;g/kg vs. 1,590 &plusmn; 66 for saline (number/mm<sup>2</sup>)] densities. Myocardial analysis revealed ~2.5 fold increase in Ki67+ cells and ~2.8-fold increase in c-kit<sup>+</sup> cells in the VEGF group, which provides evidence for cardiomyocyte regeneration and progenitor cell expansion. This study provides novel evidence of a salutary effect of VEGF in the cardiomyopathic hamster via induction of myogenic growth factor production by skeletal muscle and mobilization of progenitor cells, which resulted in attenuation of cardiomyopathy and repair of the heart.</p>
]]></description>
<dc:creator><![CDATA[Zisa, D., Shabbir, A., Mastri, M., Suzuki, G., Lee, T.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:07 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00227.2009</dc:identifier>
<dc:title><![CDATA[Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1515</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1503</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1516?rss=1">
<title><![CDATA[Maternal low-protein diet alters pancreatic islet mitochondrial function in a sex-specific manner in the adult rat]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1516?rss=1</link>
<description><![CDATA[
<p>Mitochondrial dysfunction may be a long-term consequence of a poor nutritional environment during early life. Our aim was to investigate whether a maternal low-protein (LP) diet may program mitochondrial dysfunction in islets of adult progeny before glucose intolerance ensues. To address this, pregnant Wistar rats were fed isocaloric diets containing either 20% protein (control) or 8% protein (LP diet) throughout gestation. From birth, offspring received the control diet. The mitochondrial function was analyzed in islets of 3-mo-old offspring. Related to their basal insulin release, cultured islets from both male and female LP offspring presented a lower response to glucose challenge and a blunted ATP production compared with control offspring. The expression of malate dehydrogenase as well as the subunit 6 of the ATP synthase encoded by mitochondrial genome (mtDNA) was lower in these islets, reducing the capacity of ATP production through the Krebs cycle and oxidative phosphorylation. However, mtDNA content was unchanged in LP islets compared with control. Several consequences of protein restriction during fetal life were more marked in male offspring. Only LP males showed an increased reactive oxygen species production associated with a higher expression of mitochondrial subunits of the electron transport chain NADH-ubiquinone oxireductase subunit 4L, an overexpression of peroxisome proliferator-activated receptor- and uncoupling protein-2, and a strongly reduced beta-cell mass. In conclusion, mitochondrial function is clearly altered in islets from LP adult offspring in a sex-specific manner. That may provide a cellular explanation for the earlier development of glucose intolerance in male than in female offspring of dams fed an LP diet.</p>
]]></description>
<dc:creator><![CDATA[Theys, N., Bouckenooghe, T., Ahn, M.-T., Remacle, C., Reusens, B.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00280.2009</dc:identifier>
<dc:title><![CDATA[Maternal low-protein diet alters pancreatic islet mitochondrial function in a sex-specific manner in the adult rat]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1525</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1516</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1526?rss=1">
<title><![CDATA[Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1526?rss=1</link>
<description><![CDATA[
<p>To investigate the role of brain angiotensin II (ANG II) in the pathogenesis of injury following ischemic stroke, mice overexpressing renin and angiotensinogen (R+A+) and their wild-type control animals (R&ndash;A&ndash;) were used for experimental ischemia studies. Focal brain ischemia was induced by middle cerebral artery occlusion (MCAO). The severity of ischemic injury was determined by measuring neurological deficits and histological damage at 24 and 48 h after MCAO, respectively. To exclude the influence of blood pressure and local collateral blood flow, brain slices were used for oxygen and glucose deprivation (OGD) studies. The severity of OGD-induced damage was determined by measuring indicators of tissue swelling and cell death, the intensity of the intrinsic optical signal (IOS), and the number of propidium iodide (PI) staining cells, respectively. Results showed <I>1</I>) R+A+ mice showed higher neurological deficit score (3.8 &plusmn; 0.5 and 2.5 &plusmn; 0.3 for R+A+ and R&ndash;A&ndash;, respectively, <I>P</I> &lt; 0.01) and larger infarct volume (22.2 &plusmn; 1.6% and 14.1 &plusmn; 1.2% for R+A+ and R&ndash;A&ndash;, respectively, <I>P</I> &lt; 0.01); <I>2</I>) The R+A+ brain slices showed more severe tissue swelling and cell death in the cortex (IOS: 140 &plusmn; 6% and 114 &plusmn; 10%; PI: 139 &plusmn; 20 cells/field and 39 &plusmn; 9 cells/field for R+A+ and R&ndash;A&ndash;, respectively, <I>P</I> &lt; 0.01); <I>3</I>) treatment with losartan (20 &micro;mol/l) abolished OGD-induced exaggeration of cell injury seen in R+A+ mice. The data indicate that activation of ANG II/AT<SUB>1</SUB> signaling is harmful to brain exposed to ischemia.</p>
]]></description>
<dc:creator><![CDATA[Chen, S., Li, G., Zhang, W., Wang, J., Sigmund, C. D., Olson, J. E., Chen, Y.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.91040.2008</dc:identifier>
<dc:title><![CDATA[Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1531</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1526</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1532?rss=1">
<title><![CDATA[Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1532?rss=1</link>
<description><![CDATA[
<p>During the brain's innate immune response microglia, astroglia and ependymal cells resolve/repair damaged tissue and control infection. Released interleukin-1&beta; (IL-1&beta;) reaching cerebroventricles stimulates circumventricular organs (CVOs; subfornical organ, SFO; organum vasculosum lamina terminalis, OVLT), the median preoptic nucleus (MePO), and magnocellular and parvocellular neurons in the supraoptic (SON) and paraventricular (PVN) nuclei. Hypertonic saline (HS) also activates these osmosensory CVOs and neuroendocrine systems, but, in contrast to IL-1&beta;, inhibits the peripheral immune response. To examine whether the brain's innate immune response is attenuated by osmotic stimulation, sterile acidic perfusion fluid was microdialyzed (2 &micro;l/min) in the SON area of conscious rats for 6 h with sterile HS (1.5 M NaCl) injected subcutaneously (15 ml/kg) at 5 h. Immunohistochemistry identified cytokine sources (IL-1&beta;<sup>+</sup>; OX-42<sup>+</sup> microglia) and targets (IL-1R<sup>+</sup>; inducible cyclooxygenase, COX-2<sup>+</sup>; c-Fos<sup>+</sup>) near the probe, in CVOs, MePO, ependymal cells, periventricular hypothalamus, SON, and PVN. Inserting the probe stimulated magnocellular neurons (c-Fos<sup>+</sup>; SON; PVN) via the MePO (c-Fos<sup>+</sup>), a response enhanced by HS. Microdialysis activated microglia (OX-42<sup>+</sup>; amoeboid/hypertrophied; IL-1&beta;<sup>+</sup>) in the adjacent SON and bilaterally in perivascular areas of the PVN, periventricular hypothalamus and ependyma, coincident with c-Fos expression in ependymal cells and COX-2 in the vasculature. These microglial responses were attenuated by HS, coincident with activating parvocellular and magnocellular neuroendocrine systems and elevating circulating IL-1&beta;, oxytocin, and vasopressin. Acidosis-induced cellular injury from microdialysis activated the brain's innate immune response by a mechanism inhibited by peripheral osmotic stimulation.</p>
]]></description>
<dc:creator><![CDATA[Summy-Long, J. Y., Hu, S.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00340.2009</dc:identifier>
<dc:title><![CDATA[Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1545</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1532</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1546?rss=1">
<title><![CDATA[Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1546?rss=1</link>
<description><![CDATA[
<p>Induction of heme oxygenase-1 (HO-1) in the renal medulla increases carbon monoxide and bilirubin production and decreases ANG II-mediated superoxide production. The goal of this study was to determine the importance of increases in bilirubin to the antioxidant effects of HO-1 induction in cultured mouse thick ascending loop of Henle (TALH) and inner medullary collecting duct (IMCD3) cells. Bilirubin levels were decreased by using small interfering RNAs (siRNAs) targeted to biliverdin reductase (BVR), which is the cellular enzyme responsible for the conversion of biliverdin to bilirubin. Treatment of cultured TALH or IMCD-3 cells with BVR siRNA (50 or 100 nM) resulted in an 80% decrease in the level of BVR protein and decreased cellular bilirubin levels from 46 &plusmn; 5 to 23 &plusmn; 4 nM (<I>n</I> = 4). We then determined the effects of inhibition of BVR on ANG II-mediated superoxide production. Superoxide production induced by ANG II (10<sup>&ndash;9</sup> M) significantly increased in both TALH and IMCD-3 cells. Treatment of TALH cells with BVR siRNA resulted in a significant increase in ouabain-sensitive rubidium uptake from 95 &plusmn; 6 to 122 &plusmn; 5% control (<I>n</I> = 4, <I>P</I> &lt; 0.05). Lastly, inhibition of BVR with siRNA did not prevent the decrease in superoxide levels observed in cells pretreated with the HO-1 inducer, hemin. We conclude that decreased levels of cellular bilirubin increase ANG II-mediated superoxide production and sodium transport; however, increases in bilirubin are not necessary for HO-1 induction to attenuate ANG II-mediated superoxide production.</p>
]]></description>
<dc:creator><![CDATA[Young, S. C., Storm, M. V., Speed, J. S., Kelsen, S., Tiller, C. V., Vera, T., Drummond, H. A., Stec, D. E.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90933.2008</dc:identifier>
<dc:title><![CDATA[Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1553</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1546</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1554?rss=1">
<title><![CDATA[Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1554?rss=1</link>
<description><![CDATA[
<p>Glucagon-like peptide-2 (GLP-2) is a nutrient-regulated intestinotrophic hormone derived from proglucagon in the distal intestine. Enteral nutrients (EN) potentiate the action of GLP-2 to reverse parenteral nutrition (PN)-induced mucosal hypoplasia. The objective was to determine what enteral protein component, casein, soy, or whey protein, potentiates the intestinal growth response to GLP-2 in rats with PN-induced mucosal hypoplasia. Rats received PN and continuous intravenous infusion of GLP-2 (100 &micro;g/kg/day) for 7 days. Six EN groups received PN+GLP-2 for <I>days 1&ndash;3</I> and partial PN+GLP-2 plus EN for <I>days 4&ndash;7</I>. EN was provided by ad libitum intake of a semielemental liquid diet with different protein sources: casein, hydrolyzed soy, whey protein concentrate (WPC), and hydrolyzed WPC+casein. Controls received PN+GLP-2 alone. EN induced significantly greater jejunal sucrase activity and gain of body weight, and improved feed efficiency compared with PN+GLP-2 alone. EN induced greater ileal proglucagon expression, increased plasma concentration of bioactive GLP-2 by 35%, and reduced plasma dipeptidyl peptidase IV (DPP-IV) activity compared with PN+GLP-2 alone, <I>P</I> &lt; 0.05. However, only whey protein, and not casein or soy, potentiated the ability of GLP-2 to reverse PN-induced mucosal hypoplasia and further increase ileal villus height, crypt depth, and mucosa cellularity compared with PN+GLP-2 alone, <I>P</I> &lt; 0.05. The ability of whey protein to induce greater mucosal surface area was associated with decreased DPP-IV activity in ileum and colon compared with casein, soy, or PN+GLP-2 alone, <I>P</I> &lt; 0.05. In conclusion, whey protein potentiates the action of GLP-2 to reverse PN-induced mucosal hypoplasia in association with decreased intestinal DPP-IV activity.</p>
]]></description>
<dc:creator><![CDATA[Liu, X., Murali, S. G., Holst, J. J., Ney, D. M.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00423.2009</dc:identifier>
<dc:title><![CDATA[Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1562</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1554</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1563?rss=1">
<title><![CDATA[Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1563?rss=1</link>
<description><![CDATA[
<p>Increased levels of plasminogen activator inhibitor-1 (PAI-1) have been associated with obesity, aging, insulin resistance, and type 2 diabetes, conditions that contribute to increased cardiovascular risk. PAI-1 is expressed in a variety of tissues, but the cellular origin of plasma PAI-1 is unknown. To link insulin resistance, aging, and cardiovascular disease, we examined the expression and glycosylation pattern of PAI-1 in liver and white adipose tissue (WAT) from adult (3 mo) and insulin-resistant old (24 mo) Wistar rats. Glycosylated PAI-1 protein was also purified by affinity chromatography from endothelial culture supernatans to analyze its inhibitory activity. We also analyzed the contribution of adipocytes and stromal vascular cells from WAT to PAI-1 levels with aging. Aging caused a significant increase of PAI-1 mRNA (<I>P</I> &lt; 0.001) in WAT that was predominantly due to the adipocytes and not to stroma-vascular cells, while there was no modification in liver from aged rats. Moreover, PAI-1 expression increased during preadipocyte differentiation (<I>P</I> &lt; 0.001). Furthermore, we found a tissue-dependent PAI-1 glycosylation pattern: adipose tissue only expresses the glycosylated PAI-1 form, whereas the liver mainly expresses the nonglycosylated form. Finally, we also found evidences suggesting that the glycosylated PAI-1 form shows higher inhibitory activity than the nonglycosylated. Our data suggest that WAT may be a major source of the elevated plasma levels of PAI-1 in insulin-resistant old rats. Additionally, the high degree of PAI-1 glycosylation and activity, together with the significant increase in visceral fat in old rats, may well contribute to an increased cardiovascular risk associated with insulin-resistant states.</p>
]]></description>
<dc:creator><![CDATA[Serrano, R., Barrenetxe, J., Orbe, J., Rodriguez, J. A., Gallardo, N., Martinez, C., Andres, A., Paramo, J. A.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00093.2009</dc:identifier>
<dc:title><![CDATA[Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1569</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1563</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1570?rss=1">
<title><![CDATA[Evolutionary structural and functional conservation of an ortholog of the GLUT2 glucose transporter gene (SLC2A2) in zebrafish]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1570?rss=1</link>
<description><![CDATA[
<p>In mammals, GLUT2 plays an essential role in glucose homeostasis. From an evolutionary perspective, relatively little is known about the biology of GLUT2, or other GLUTs, in nonmammalian vertebrates. Here, we have conducted studies to functionally characterize GLUT2 in zebrafish. First, we cloned the zebrafish ortholog of GLUT2 (zfGLUT2) encoding a protein of 504 amino acids with high-sequence identity to other known vertebrate GLUT2 proteins. The zfGLUT2 gene consists of 11 exons and 10 introns, spanning 20 kb and mapping to a region of chromosome 2 that exhibits conserved synteny with human chromosome 3. When expressed in <I>Xenopus</I> oocytes, zfGLUT2 transported 2-deoxyglucose (2-DG) with similar affinity than mammalian GLUT2 (<I>K</I><SUB>m</SUB> of 11 mM). Transport of 2-DG was competed mostly by <scp>d</scp>-fructose and <scp>d</scp>-mannose and was inhibited by cytochalasin B. During early development, zfGLUT2 expression was detected already at 10 h postfertilization and remained elevated in 5-day larvae, when it was clearly localized to the liver and intestinal bulb. In the adult, zfGLUT2 expression was highest in testis, brain, skin, kidney, and intestine, followed by liver and muscle. In the intestine, zfGLUT2 transcripts were detected in absorptive enterocytes, and its mRNA levels were altered by fasting and refeeding, suggesting that its expression in the intestine may be regulated by the nutritional status. These results indicate that the structure and function of GLUT2 has been remarkably well conserved during vertebrate evolution and open the way for the use of zebrafish as a model species in which to study the biology and pathophysiology of GLUT2.</p>
]]></description>
<dc:creator><![CDATA[Castillo, J., Crespo, D., Capilla, E., Diaz, M., Chauvigne, F., Cerda, J., Planas, J. V.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00430.2009</dc:identifier>
<dc:title><![CDATA[Evolutionary structural and functional conservation of an ortholog of the GLUT2 glucose transporter gene (SLC2A2) in zebrafish]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1581</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1570</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1582?rss=1">
<title><![CDATA[Physiological response to extreme fasting in subantarctic fur seal (Arctocephalus tropicalis) pups: metabolic rates, energy reserve utilization, and water fluxes]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1582?rss=1</link>
<description><![CDATA[
<p>Surviving prolonged fasting requires various metabolic adaptations, such as energy and protein sparing, notably when animals are simultaneously engaged in energy-demanding processes such as growth. Due to the intermittent pattern of maternal attendance, subantarctic fur seal pups have to repeatedly endure exceptionally long fasting episodes throughout the 10-mo rearing period while preparing for nutritional independence. Their metabolic responses to natural prolonged fasting (33.4 &plusmn; 3.3 days) were investigated at 7 mo of age. Within 4&ndash;6 fasting days, pups shifted into a stage of metabolic economy characterized by a minimal rate of body mass loss (0.7%/day) and decreased resting metabolic rate (5.9 &plusmn; 0.1 ml O<SUB>2</SUB>&middot;kg<sup>&ndash;1</sup>&middot;day<sup>&ndash;1</sup>) that was only 10% above the level predicted for adult terrestrial mammals. Field metabolic rate (289 &plusmn; 10 kJ&middot;kg<sup>&ndash;1</sup>&middot;day<sup>&ndash;1</sup>) and water influx (7.9 &plusmn; 0.9 ml&middot;kg<sup>&ndash;1</sup>&middot;day<sup>&ndash;1</sup>) were also among the lowest reported for any young otariid, suggesting minimized energy allocation to behavioral activity and thermoregulation. Furthermore, lean tissue degradation was dramatically reduced. High initial adiposity (&gt;48%) and predominant reliance on lipid catabolism likely contributed to the exceptional degree of protein sparing attained. Blood chemistry supported these findings and suggested utilization of alternative fuels, such as &beta;-hydroxybutyrate and de novo synthesized glucose from fat-released glycerol. Regardless of sex and body condition, pups tended to adopt a convergent strategy of extreme energy and lean body mass conservation that appears highly adaptive for it allows some tissue growth during the repeated episodes of prolonged fasting they experience throughout their development.</p>
]]></description>
<dc:creator><![CDATA[Verrier, D., Groscolas, R., Guinet, C., Arnould, J. P. Y.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.90857.2008</dc:identifier>
<dc:title><![CDATA[Physiological response to extreme fasting in subantarctic fur seal (Arctocephalus tropicalis) pups: metabolic rates, energy reserve utilization, and water fluxes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1592</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1582</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1593?rss=1">
<title><![CDATA[Natural antibodies and complement modulate intimal thickening after arterial injury]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1593?rss=1</link>
<description><![CDATA[
<p>Immune factors are involved in modulating neointimal response to arterial wall injury, but the role of individual immune effectors in this response remains unclear. Using a carotid cuff injury model in mice, we tested the role of immunoglobulin isotypes in modulating intimal thickening by using adoptive transfer of splenocytes from WT mice, or the direct administration of IgG or IgM into immune-deficient Rag-1&ndash;/&ndash; [Rag-1 knockout (Rag-1KO)] mice. The direct role of complement was also tested by depletion of complement. Splenocytes from WT mice were isolated and adoptively transferred to Rag-1KO mice subjected to carotid cuff arterial injury. Transfer of splenocytes to Rag-1KO mice resulted in increased serum IgM and IgG within 48 h and were comparable to WT levels by 21 days after injury. Splenocyte transfer in Rag-1KO decreased intimal area by 40% compared with Rag-1KO mice without cell transfer. To further differentiate the relative contribution of IgM or IgG in reducing intimal thickening, additional groups of Rag-1KO mice were subjected to injury and given intravenous injections of pooled mouse IgG or IgM. Both IgG and IgM treatment significantly reduced intimal thickening compared with untreated Rag-1KO mice. Immunoglobulin treatments modified serum complement C3 profile and decreased C3 presence in injured arteries. Depletion of C3 using cobra venom factor in Rag-1KO mice significantly decreased intimal thickening. Our results identify the direct role of natural IgG and IgM, and complement in the modulation of neointimal response to arterial injury.</p>
]]></description>
<dc:creator><![CDATA[Dimayuga, P. C., Cesena, F. H. Y., Chyu, K.-Y., Yano, J., Amorn, A., Fishbein, M. C., Shah, P. K., Cercek, B.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00114.2009</dc:identifier>
<dc:title><![CDATA[Natural antibodies and complement modulate intimal thickening after arterial injury]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1600</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1593</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1601?rss=1">
<title><![CDATA[Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1601?rss=1</link>
<description><![CDATA[
<p>Hypocretins/orexins act through two receptor subtypes: OX<SUB>1</SUB> and OX<SUB>2</SUB>. Outside the brain, orexin receptors are expressed in adrenal glands, where orexins stimulate the release of glucocorticoids. To further address the regulation of steroidogenesis, we analyzed the effect of orexins on the expression of steroidogenic enzymes in human adrenocortical National Cancer Institute (NCI) H295R cells by qPCR. In NCI H295R cells, OX<SUB>2</SUB> receptors were highly expressed, as they were in human adrenal glands. After treatment of NCI H295R cells with orexin A for 12&ndash;24 h, the cortisol synthesis rate was significantly increased, whereas 30 min of treatment showed no effect. While CYP11B1 and CYP11B2 mRNA levels were increased already at earlier time points, the expression of HSD3B2 and CYP21 mRNA was significantly up-regulated after treatment with orexin A for 12 h. Likewise, orexin B increased CYP21 and HSD3B2 mRNA levels showing, however, a lower potency compared with orexin A. The mRNA levels of CYP11A and CYP17 were unaffected by orexin A. OX<SUB>2</SUB> receptor mRNA levels were down-regulated after 12 and 24 h of orexin A treatment. Orexin A increased intracellular Ca<sup>2+</sup> but not cAMP concentrations in NCI H295R cells. Furthermore, inhibition of PKC and MAPK kinase/ERK kinase (MEK1/2) prevented the increase of HSD3B2 expression by orexin A. Accordingly, orexin A treatment of NCI H295R cells markedly enhanced ERK1/2 phosphorylation that was prevented by PKC and, in part, PKA inhibition. In conclusion, orexins may influence adrenal steroidogenesis by differential regulation of the expression of steroidogenic enzymes involving Ca<sup>2+</sup>, as well as PKC-ERK1/2 signaling.</p>
]]></description>
<dc:creator><![CDATA[Wenzel, J., Grabinski, N., Knopp, C. A., Dendorfer, A., Ramanjaneya, M., Randeva, H. S., Ehrhart-Bornstein, M., Dominiak, P., Johren, O.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.91034.2008</dc:identifier>
<dc:title><![CDATA[Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1609</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1601</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1610?rss=1">
<title><![CDATA[Endolymphatic sac is involved in the regulation of hydrostatic pressure of cochlear endolymph]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1610?rss=1</link>
<description><![CDATA[
<p>To clarify the role of the endolymphatic sac (ES) in the regulation of endolymphatic pressure, the effects of isoproterenol, a &beta;-adrenergic receptor agonist, and acetazolamide, a potent carbonic anhydrase inhibitor, both of which decrease ES direct current potential on cochlear hydrostatic pressure, were examined in guinea pigs. When isoproterenol was applied intravenously, hydrostatic pressures of cochlear endolymph and perilymph were significantly increased with no change in endocochlear potential or the hydrostatic pressure of cerebrospinal fluid. Acetazolamide produced no marked change in the hydrostatic pressure of cochlear endolymph. In ears with an obstructed ES, the action of isoproterenol on the hydrostatic pressure of cochlear endolymph and perilymph was suppressed. These results suggest that the ES may regulate the hydrostatic pressure of the endolymphatic system via the action of the agents such as catecholamines on the ES.</p>
]]></description>
<dc:creator><![CDATA[Inamoto, R., Miyashita, T., Akiyama, K., Mori, T., Mori, N.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00073.2009</dc:identifier>
<dc:title><![CDATA[Endolymphatic sac is involved in the regulation of hydrostatic pressure of cochlear endolymph]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1614</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1610</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1615?rss=1">
<title><![CDATA[Insulin-like growth factor-II regulates maternal hemodynamic adaptation to pregnancy in rats]]></title>
<link>http://ajpregu.physiology.org/cgi/content/abstract/297/5/R1615?rss=1</link>
<description><![CDATA[
<p>The relationship between maternal plasma volume (PV) expansion and fetal growth is well established, but the underlying mechanisms remain unclear. Here, we examined the influence of maternal body weight and fetoplacental mass on gestational PV increment in the rat. Because IGF-I and IGF-II have growth-promoting and vasoactive properties, their relationship to PV expansion and fetoplacental growth was also studied. In normal rats, the gradual expansion of PV (+35% at <I>day 22</I>, i.e., term) was accompanied by a rise in circulating IGF-II (+45%) and a considerable drop in IGF-I (&ndash;73%). Increased maternal body weight induced by an obesogenic diet did not influence PV and circulating IGFs compared with rats on the standard diet. Combining the results from both diets, circulating IGF-II was the principal correlate of PV. A second experiment examined the effect of fetoplacental mass reduction by surgically removing half of the gestational sacs at <I>day 16</I>. This procedure reduced maternal PV and circulating IGF-II at term by 14% and 20%, respectively. We then investigated the effect of a constant infusion of IGF-II (1 mg&middot;kg<sup>&ndash;1</sup>&middot;day<sup>&ndash;1</sup>) from <I>day 16</I>, which raised circulating IGF-II by 38% and found increased PV (+19%) and a larger placental trophospongial area (+29%) at term. Our results indicate that the placenta, the primary source of IGF-II synthesis in pregnancy, drives PV expansion, and that IGF-II is among the regulatory factors of the gestational PV increment. Further studies should clarify whether IGF-II directly affects vascular function and/or indirectly promotes the secretion of placenta-derived vasoactive substances.</p>
]]></description>
<dc:creator><![CDATA[Van Mieghem, T., van Bree, R., Van Herck, E., Deprest, J., Verhaeghe, J.]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.00463.2009</dc:identifier>
<dc:title><![CDATA[Insulin-like growth factor-II regulates maternal hemodynamic adaptation to pregnancy in rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1621</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1615</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/full/297/5/R1622?rss=1">
<title><![CDATA[Corrigendum]]></title>
<link>http://ajpregu.physiology.org/cgi/content/full/297/5/R1622?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.zh6-6979-corr.2009</dc:identifier>
<dc:title><![CDATA[Corrigendum]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1623</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1622</prism:startingPage>
<prism:section>Corrigenda</prism:section>
</item>

<item rdf:about="http://ajpregu.physiology.org/cgi/content/full/297/5/R1624?rss=1">
<title><![CDATA[Corrigendum]]></title>
<link>http://ajpregu.physiology.org/cgi/content/full/297/5/R1624?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Fri, 30 Oct 2009 10:13:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpregu.zh6-7009-corr.2009</dc:identifier>
<dc:title><![CDATA[Corrigendum]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>R1624</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>R1624</prism:startingPage>
<prism:section>Corrigenda</prism:section>
</item>

</rdf:RDF>